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Abstract 
With age, the cardiovascular system experiences substantial alterations in cellular 
morphology and function.  The factors regulating these changes are unknown; however, 
the mitogen activated protein kinase (MAPK) pathways have emerged as critical 
components for mediating numerous cellular responses including control of cell growth, 
differentiation and adaptation.  Here we compare the expression, basal activation and the 
ability of increased  pressure to activate the MAPK pathways in adult (6 month old), aged 
(30 month old) and very aged (36 month old) Fischer 344 x Brown Norway F1 Hybrid 
rats.  Histochemical analysis demonstrated an age-related increase in tunica media 
thickness of approximately 11% and 21% in aortae from aged and very aged animals, 
respectively.  Western blot analysis of the MAPK family extracellular signal-regulated 
kinase (ERK 1/2), p38, and c-Jun NH2 -terminal kinase (JNK) MAPKs showed 
differential expression and activation among these proteins with age.  Expression of ERK 
1/2, p38, and JNK were unchanged, slightly increased (10 ± 17.5%) or significantly 
increased (72.3 ± 27%), respectively, in very aged aortae. By comparison, basal 
activation levels of these proteins were reduced (-26.2 ± 7.4%), markedly increased (97.0 
± 16.8%) and slightly increased (14.4 ± 4.5%), respectively, in very aged versus 6-month 
rat aortae.  An acute increase of aortic intraluminal pressure (200 mm Hg) indicated that 
ERK 1/2 regulation differed from p38 or JNK.  Pressure loading-induced phosphorylation 
of ERK1/2 was unchanged or increased with aging while p38 and JNK phosphorylation 
was attenuated (P<0.01).  These observations confirm previous conclusions that MAPK 
proteins are mechanically regulated and expand these studies to suggest that MAPK 
expression and the control of activation are changed with aging. 
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 Chapter 1 
INTRODUCTION 
 By the year 2030, the number of older Americans will double from the current 35 
million people over the age of 65.  The risk of coronary artery disease, hypertension, 
congestive heart failure, and stroke greatly increase with age, and with advanced aging 
the incidence and prevalence of these diseases steeply raise.  Through the many 
improvements in health care and modern medical science the elderly now comprise the 
fastest growing segment of the population in the United States (Census, 1990).  
Cardiovascular diseases (CVD) have reached epidemic proportions on a global 
dimension, with hypertension, cardiovascular diseases, and heart related illnesses a major 
health concern throughout the United States and the world.  More than 30% of all deaths 
worldwide are due to cardiovascular diseases. Cardiovascular diseases are expected to be 
the leading cause of mortality and disability by the year 2020, surpassing even infectious 
diseases. (66)  
 Little is known about the normal aging process involved in vascular smooth 
muscle. This is due primarily to the emphasis on vascular smooth muscle diseases within 
symptomatic patients.  Understanding true age related changes may lead us to a better 
understanding of the true nature of CVD. To determine the threshold at which these 
disease mechanisms manifest themselves into pathological illness we must consider age-
associated changes in cardiovascular structure and function along with pathophysiologic 
disease mechanisms.  Gerontological investigations can be compromised when the 
difference observed between young and old animals are actually different between 
normal and diseased states. Animals chosen for investigation of age-related phenomena 
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should have certain characteristics (136).  Mortality rates should increase exponentially 
with chronological age indicating a  population aging naturally without perturbation by 
infectious disease and poor diet (59)  Thus far, several strains and lines of rats have been 
used in gerontological investigations, including he Wistar, Brown Norway, Sprague-
Dawley, and with the greatest frequency in literature the Fisher 344 (F344) (81).  
However, recent reports detailing an absence of age associated changes in F344 muscle 
morphology (23) along with an increased degree of lesion formation in the aging F344 
model and other rat strain models have suggested that the F1 hybrid rat strain may be 
more suitable for gerontological investigation (81, 119).  Recently, on the basis of these 
pathological assessments the National Institute of Aging (NIA) has recommended the F1 
hybrid as the superior1 animal model for aging research and has selected the F1 hybrid 
model to be the standard rat strain to be used by the NIA to conduct gerontological 
research (119). 
 To date only two published reports, (104) (131) have investigated age associated 
alteration in smooth muscle in the F1 model. However, only one addressed vascular 
smooth muscle changes with age (131).  These researchers demonstrated marked 
increases in vitamin A in aged aortic vessel walls (131). No further research has been 
conducted to characterize other age associated alterations in the vasculature of these 
animals. Furthermore, no research has examined the ability of vascular smooth muscle 
(VSM) from these animals of different ages to adapt to alteration in pressure. 
The fundamental mechanism, whereby mechanical stress acts upon a cell to 
initiate intracellular signaling, is known as mechanotrasduction. This mechanism is 
implemented in many cell types.  Processes governing tissue architecture (18, 112, 132, 
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145), metabolic response (48), and cellular growth and survival (26) (105), all utilize 
mechanotransdution.   Sensitivity to mechanical forces appear in all adhesion-dependents 
cells (105, 134) no where is this more evident than in mechanocytes or cells routinely 
subjected to mechanical forces, such as skeletal muscle sells (31, 132), osteocytes (95), 
chondrocytes (47, 140), airway smooth muscle cells (114, 115), cardiomyocytes (107, 
112, 142, 143), vascular endothelial (85)and smooth muscle cells (99).  
Mitogen-activated protein kinase (MAPK) cascades involvement in mechanically 
induced signaling remains consistent across various cell types (2, 36, 47, 49, 62, 79, 107, 
109-111, 142, 143, 147). MAPK activation has been linked to many extra-cellular 
mechanisms.  MAPKs may act as points of convergence for various cell signaling 
cascades triggering gene expression (29).   
 Recently, three parallel cascades of MAPKs have been described in mammalian 
cells: extracellular signal-regulated kinase p42/44 (ERK 1/2), p38, and c-Jun NH-
terminal kinase (JNK)/stress-activated protein kinase (SAPK).  ERK1/2 and p38 MAPK 
pathways have been proposed as the most likely modulators of vascular smooth muscle 
contraction (21, 65, 91, 94, 135, 144).  Within the large conduit vessel, in which 
intraluminal pressure induced spontaneous tone is not developed, MAPK have been 
shown to be phosphorylated and activated by mechanical stretch (4, 82, 98)  However, 
how this mechanical stretch induced phosphorylation is altered with age is unknown. Yet 
another area which has been poorly addressed is if stretch induced phosphorylation is a 
true physiological response for VSMC.  The concern raised by this line of thought leads 
us to the question, does mechanical stretch truly model force perception or transduction 
experienced by VSMC under hypertensive pressures?  
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 Although not well understood, the increased risk of CVD with aging is thought, in 
part, to be due to age-associated changes in cardiovascular structure and / or function.  
How aging may affect the ability of the vascular to initiate and respond to physiological 
stimuli has not been well studied.  Recent studies have demonstrated that increased 
mechanical stretch is, by itself, able to influence smooth muscle cell proliferation, the 
production of extracellular matrix protein, actin synthesis, and smooth muscle cell size.  
These data suggest that mechanical stimuli are important in regulating vascular structure 
and function.  The precise pathways regulating stretch-induced alterations in vascular 
phenotype are not known however vessel stretch leads to the activation of protein kinase 
C and the mitogen activated protein kinase (MAPK) pathways (111, 133).  Although the 
effects of mechanical stress could be mediated in part, by activation of mechanosensitive 
ion channels or by locally and systemically released growth factors,  the seminal studies 
of Ingber and others (50-57) have demonstrated that mechanical input itself is able to 
trigger cellular signaling mechanisms through the process of mechanotransduction.  How 
mechanotransduction occurs in fully differentiated vascular tissues and how aging affects 
these processes is not known. 
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PURPOSE  
 The purposes of this research project are to examine: 1) whether alterations in age 
change the basal levels of extracellular signal-regulated kinase p42/44 (ERK 1/2), p38, 
and c-Jun NH-terminal kinase (JNK)/stress-activated protein kinase (SAPK) protein 
expression 2) and whether aging affects the way in which the aorta activates these 
MAPKs pathways. Alteration in basal levels of protein expression and changes in 
pathway signaling may point toward a key in understanding age-associated pathology.  
Determining these alterations may lead to steps for early intervention in pathological 
onset. 
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SPECIFIC AIMS 
 The marked increase in vessel wall thickness and increased stiffening 
(arteriosclerosis) is one of the major problems in aging.  The long-term goals of this study 
are to understand the cellular mechanisms that might regulate adaptations to increased 
vessel wall thickness. The goals of this study are to firstly, determine the comparative 
extent of the aging alteration on vascular smooth muscle basal MAPKs expression in the 
F1 rat model and secondly to determine if the activation of these pathways are altered 
with age. 
 
Specific Aim #1  
To determine if the basal levels of MAPKs are altered with age. 
 Hypothesis:  Aging will alter aortic MAPK content and basal 
phosphorylation. 
 
Specific Aim #2  
To determine if the pressure induced phosphorylation of the MAPK pathway is 
altered with age. 
 Hypothesis:  Aging will alter the extent of aortic MAPK phosphorylation 
following an increase in intraluminal pressure. 
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Figures and Legends  
Figure 1-1  
 
Figure 1 – 1  This is a representation of the anatomy from which the vessel sections 
were taken. 
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Figure 1-2  
 
  
Figure 1 – 2 This is a representative model of the pressurization system designed by the 
author. 
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Chapter 2 
Review of Literature 
INTRODUCTION
 
 The following chapter presents a review of the pertinent literature concerning the 
present study.  Specifically, the following areas will be addressed: 1.) Mitogen activated 
kinases and the regulation of MAPK activity by mechanical stimuli and 2.) the F344XBN 
strain as an aging model for cardiovascular investigation. 
 
Age associated alterations in vascular smooth muscle 
 Vascular aging contributes to the age-dependent rise in hypertension and 
atherosclerotic disease and the chronic heart failure or stroke that result from these 
diseases.  Recent studies examining large cohorts have demonstrated that aging, by itself, 
confers a greater risk for cardiovascular diseases (CVD) than do the other major risk 
factors such as plasma lipid levels, smoking, diabetes, or sedentary life style (19).  
Although not well understood, the increased risk of CVD with aging is thought, in part, to 
be due to age-associated changes in cardiovascular structure and / or function.  Age-
associated remodeling of the wall of large arteries of rodents and nonhuman primates is 
quite similar to that observed in humans and includes luminal dilation, intimal and medial 
thickening, and endothelial dysfunction (68). The mechanisms and etiology responsible 
for the age-related changes in vascular smooth muscle physiology and function are quite 
complex and not well understood.    
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Mitogen activated kinases and the regulation of MAPK activity by mechanical 
stimuli  
 Recent studies have demonstrated that increased mechanical stretch is, by itself, 
able to influence smooth muscle cell proliferation, the production of extracellular matrix 
protein, actin synthesis, and smooth muscle cell size.  These data suggest that mechanical 
stimuli are important in regulating vascular structure and function.  The precise pathways 
regulating stretch-induced alterations in vascular phenotype are not known.  Although the 
effects of mechanical stress could be mediated in part, by activation of mechanosensitive 
ion channels or by locally and systemically released growth factors,  the seminal studies 
of Ingber and others (50-57) have demonstrated that mechanical input itself is able to 
trigger cellular signaling mechanisms through the process of mechanotransduction.  How 
mechanotransduction occurs in fully differentiated vascular tissues and how aging affects 
these processes is not known.  Processes governing tissue architecture (18, 112, 132, 
145), metabolic response (48), and cellular growth and survival (26) (105), all utilize 
mechanotransdution.  Sensitivity to mechanical forces appears in all adhesion-dependents 
cells (105, 134) with this property being particularly evident in the mechanocytes or cells 
routinely subjected to mechanical forces, such as skeletal muscle sells (31, 132), 
osteocytes (95), chondrocytes (47, 140), airway smooth muscle cells (114, 115), 
cardiomyocytes (107, 112, 142, 143), vascular endothelial (85)and smooth muscle cells 
(99).  
The involvement of the mitogen-activated protein kinase (MAPK) cascades in 
mechanically induced signaling remains consistent across various cell types (2, 36, 47, 
49, 62, 79, 107, 109-111, 142, 143, 147).  MAPKs may act as points of convergence for 
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various cell signaling cascades triggering gene expression (29).  The MAPK pathway is 
one of the most significant signaling systems used by an organism to elicit a variety of 
responses at the cellular level. 
 Recently, three parallel cascades of MAPKs have been described in mammalian 
cells: extracellular signal-regulated kinase p42/44 (ERK), p38, and cJun NH-terminal 
kinase (JNK).  The MAPK response to chemical and mechanical stresses is regulated 
through substrate-level phosphorylation of three-tiered cascades composed of a MAPK, a 
MAPK kinase (MEK), and a MEK kinase (MEKK) (24).  MAPKs are activated through 
dual phosphorylation on threonine and tyrosine residues.  Multiple factors have been 
shown to activate substrate level phosphorylation of MAPKs including hormones, growth 
factors, reactive oxygen species, decreases in pH, and mechanical stress (138).  Of the 
currently identified MAPKs the ERK1/2 and p38 MAPK pathways have been proposed 
as the most likely modulators of vascular smooth muscle contraction (21, 65, 91, 94, 135, 
144).  Within the large conduit vessel, in which intraluminal pressure induced 
spontaneous tone is not developed, MAPK proteins have been shown to be 
phosphorylated and activated by mechanical stretch (4, 82, 98)  However, how this 
mechanical stretch induced phosphorylation is altered with age is unknown.  
 
Summary 
  Since it is unclear whether aging affects the ability of vascular smooth muscle to 
respond to mechanical stimulation, it remains possible that both aging or age related 
changes in tissue structure and function may contribute to the observed age associated 
changes in MAPK mechanotransduction.  This age-associated change of vascular smooth 
Kevin M. Rice Page 21 4/22/2005  
muscle structure leads to an altered ability to respond to force and eventually, a decreased 
functional capacity. 
 
The F344XBN strain as an aging model for cardiovascular investigation. 
 Age-associated remodeling of the wall of large arteries of rodents and nonhuman 
primates is quite similar to that observed in humans and includes luminal dilation, intimal 
and medial thickening, and endothelial dysfunction(15, 16, 20, 23, 30).  In an attempt to 
provide a better rodent aging model, the National Institute on Aging has developed the 
Fischer 344/Brown Norway F1 Hybrid (F33XBN).  The generation of this model is 
important because studies have demonstrated that these animals age with minimal 
disease(81, 119) while often living longer, presumably because of their better health. 
Despite a number of studies examining the Fischer 344 X Brown Norway (F1) rat strain 
as a model of human skeletal muscle atrophy (3, 7, 10-14, 17, 22, 25, 32, 34, 35, 40-42, 
72-74, 83, 89, 90, 92, 96, 97, 101, 106, 116, 122, 125, 129, 130), the use of the F344XBN 
(F1) rat model for vascular smooth muscle research has been limited.  Spinetti et al, 
addressed MCP-1 and its receptor CCR2 in aortic VSMCs in the F344XBN. They found 
that MCP-1 and CCR2 mRNAs and proteins increased with age. They concluded that 
MCP-1/CCR2 signaling my play a role in age-associated arterial remodeling. Smith et al 
addressed vascular endothelial dysfunction in aging aortas. Based on research from their 
lab, they indicate a decrease in eNOS phosphorylation with age; they attribute this loss to 
deceases in AKT basil levels of phosphorylation.  And  Gaballa et al examined large 
artery remodeling in aortas during aging: biaxial passive and active stiffness (28, 113, 
118). They document increases in media thickness, collagen content, and collagen/elastin 
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ratio in the carotid arteries with age. Also of interest is their finding of decrease in elastin 
density, and the number of smooth muscle cell nuclei. Taken together, these data suggest 
that multiple factors are involved in age associated changes in vascular smooth muscle 
phenotypic properties, and that the structural changes that occur with age are associated 
with changes in active and passive stiffness, as well as changes in protein expression and 
activation levels. 
  Due of this lack of study, our present research utilizes this model selected by the 
NIH as a model for human aging, and addresses the use of the F344XBN rat strain as a 
model for cardiovascular aging in humans.    
 
 Summary  
 The declines in functional capacity with advancing age in humans are well 
documented.  Much of the evidence in the literature to date suggests that the loss of 
physiologic function observed with advancing age is reversible, perhaps even in the frail 
elderly.  Due to the methodological shortcomings associated with performing invasive 
measures in aged humans, little is known about how aging influences cellular signal 
transduction.  Research concerning cardiovascular aging research in rodent models is 
almost nonexistent. The need for the development of a rodent model that effectively 
mimics human vascular aging and morphology is extremely important due to the 
detrimental effects seen in cardiovascular pathology in humans.   
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Chapter 3  
EFFECTS OF AGING ON PRESSURE-INDUCED MAPK ACTIVATION IN THE 
RAT AORTA 
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Abstract 
With age, the cardiovascular system experiences substantial alterations in cellular 
morphology and function.  The factors regulating these changes are unknown; however, 
the mitogen activated protein kinase (MAPK) pathways have emerged as critical 
components for mediating numerous cellular responses including control of cell growth, 
differentiation and adaptation.  Here we compare the expression, basal activation and the 
ability of increased  pressure to activate the MAPK pathways in adult (6 month old), aged 
(30 month old) and very aged (36 month old) Fischer 344 x Brown Norway F1 Hybrid 
rats.  Histochemical analysis demonstrated an age-related increase in tunica media 
thickness of approximately 11% and 21% in aortae from aged and very aged animals, 
respectively.  Western blot analysis of the MAPK family extracellular signal-regulated 
kinase (ERK 1/2), p38, and c-Jun NH2 -terminal kinase (JNK) MAPKs showed 
differential expression and activation among these proteins with age.  Expression of ERK 
1/2, p38, and JNK were unchanged, slightly increased (10 ± 17.5%) or significantly 
increased (72.3 ± 27%), respectively, in very aged aortae. By comparison, basal 
activation levels of these proteins were reduced (-26.2 ± 7.4%), markedly increased (97.0 
± 16.8%) and slightly increased (14.4 ± 4.5%), respectively, in very aged versus 6-month 
rat aortae.  An acute increase of aortic intraluminal pressure (200 mm Hg) indicated that 
ERK 1/2 regulation differed from p38 or JNK.  Pressure loading-induced phosphorylation 
of ERK1/2 was unchanged or increased with aging while p38 and JNK phosphorylation 
was attenuated (P<0.01).  These observations confirm previous conclusions that MAPK 
proteins are mechanically regulated and expand these studies to suggest that MAPK 
expression and the control of activation are changed with aging. 
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Introduction 
Cardiovascular disease (CVD), which is responsible for more than 30% of all 
deaths worldwide, is expected to be the leading cause of mortality and disability by the 
year 2020, surpassing even infectious diseases (66, 67, 69-71).  Aging is the single largest 
risk factor for CVD, making heart failure the leading cause of death of individuals over 
the age of 65 years.  It is thought that the impact of age on the risk of the occurrence, 
severity, and prognosis of cardiovascular disease is due, in part, to age-associated 
changes in cardiovascular structure and/or function.  However this hypothesis has not 
been well studied.  The lack of information concerning the effects of aging on the 
vasculature is not surprising when one considers the difficulties associated with human 
aging studies, e.g. cross-sectional design and an inability to control for lifetime activity 
patterns.  Because of these methodological difficulties, many aging vascular studies have 
been performed using the rat.  However, many rat strains such as the Fisher 344, 
Sprague-Dawley, Long-Evans, and Wistar fail to exhibit a similar degree of age-
associated muscle atrophy or muscle impairment when compared to humans. (23, 43)  
The reasons for differences between the aging human and rat are not entirely known.  
However, inconsistencies may in part be explained by the use of rat strains prone to 
premature death, age related disease, or variations in the specific muscles evaluated.  In 
an attempt to minimize these confounding variables, the National Institute on Aging has 
developed the Fischer 344/Brown Norway F1 Hybrid as a rodent model for age-related 
physiological studies.  The generation of this model is important because studies have 
demonstrated that these animals age with minimal disease (81, 119) while often living 
longer, presumably because of their better health.  For example, male rats of the Fischer 
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344 and Brown Norway strains are reported to have median life spans of 103 and 129 
weeks, respectively; whereas, their F1 hybrid has a median life span of 145 weeks when 
fed ad libitum.  To our knowledge: however, the F1 hybrid model has not yet been 
utilized for the investigation of aging effects on the physiological signaling of vascular 
smooth muscle.  In the present study, we employed probability of survival curves 
generated by the NIA for the F1 hybrid strain to ensure that the rats used in this study 
corresponded roughly to humans in their third, sixth, and eighth decade of life.  This 
latter time point was chosen because cardiovascular dysfunction in humans accelerates 
during the eighth decade of life, and because this age represents one of the fastest 
growing segments of the aging population in the United States.   
Blood pressure induces mechanical stress on vascular smooth muscle that, if 
excessive, leads to adaptive remodeling in the form of smooth muscle hypertrophy and 
hyperplasia. (58, 88, 93)  In addition to adaptive remodeling, excessive wall strain causes 
vascular inflammation, which has been implicated in the pathogenesis of 
atherosclerosis.(38)  The factors regulating these changes are unknown; however, the 
mitogen activated protein kinase (MAPK) pathways have been identified as important 
signaling proteins involved in the control of cell growth, differentiation and adaptation. 
Three parallel cascade pathways of MAPK intracellular signaling have been described: 
the extracellular signal-regulated kinases (ERK1/2), c-Jun NH2 -terminal kinase (JNK), 
and p38 kinase.  These pathways require duel phosphorylation on threonine and tyrosine 
residues by specific upstream proteins to initiate their signaling mechanism. (8, 9, 16, 39, 
63, 84, 103, 123, 146)  Studies in rats and humans have implicated the MAPK signaling 
network in the regulation of protein synthesis, mRNA stability, as mediators of apoptosis 
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and the inflammatory response, and as key players in the control of load-induced 
alterations in protein expression.(30, 46, 93, 141)   While these data together suggest that 
MAPK signaling plays an important role in the regulation of gene expression, it is still 
not known how MAPK activity is regulated with aging.    
We hypothesized that aging will alter the ability of vessels to appropriately 
initiate intracellular signaling to mechanical load (stretch).  Hence, we propose that 
altered mechanotransduction may contribute to age-related changes in vascular smooth 
muscle morphology and function.  In the present study, we compared resting levels and 
the MAPK phosphorylation after increases in intraluminal pressure in isolated aortae 
from different age groups of Fisher 344/Brown Norway F1 hybrid rats.  The results 
suggest significant alteration in MAPK expression and stress-induced activation with 
aging.  
 
Material and Methods 
Animals  
 All procedures were performed in accordance with the Guide for the Care and 
Use of Laboratory Animals as approved by the Council of the American Physiological 
Society and the Animal Use Review Board of The Marshall University.  All procedures 
were conducted in strict accordance with Public Health Service animal welfare policy.  
Adult (6 months),  aged (30 months) and very aged (36 months) male F1 rats were 
obtained from the National Institute on Aging.  Rats were barrier housed two per cage in 
an AAALAC approved vivarium.  Housing conditions consisted of a 12H: 12H dark-light 
cycle and temperature was maintained at 22 ± 2 °C.  Animals were provided food and 
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water ad libitum.  Rats were allowed to recover from shipment for at least two weeks 
before experimentation began, and during this time the animals were carefully observed 
and weighed weekly.  None of the older animals exhibited signs of failure to thrive, such 
as precipitous weight loss, disinterest in the environment, or unexpected gait alterations.  
Systolic blood pressure was determined with the animal unanesthetized using a 
programmed electrosphygmomanometer with pneumatic tail cuff (Narco-Biosystems, 
Houston, TX).  Animals were acclimated to the procedure for a minimum of 3 days prior 
to obtaining blood pressure. 
 
Materials 
Anti-p38 MAPK, JNK, and p44/42 MAPK (ERK1/2) mouse IgG and rabbit IgG 
antibodies were purchased from Cell Signaling Technology (Beverly, MA).  Precast 10% 
SDS-PAGE gels were procured from Cambrex Biosciences (Baltimore, MD), and 
enhanced chemiluminescence (ECL) western blot detection reagent was from Amersham 
Biosciences (Piscataway, NJ).  Restore western blot stripping buffer was obtained from 
Pierce (Rockford, IL) and 3T3 cell lysates were from Santa Cruz Biotechnology (Santa 
Cruz, CA).  All other chemicals were purchased from Sigma (St. Louis, MO).  
 
Isolated Vessel Protocol 
 Rats were anesthetized with a ketamine-xylazine (1:4) cocktail (50 mg/kg ip) and 
supplemented as necessary for reflexive response. In a sterile aseptic environment, the 
ventral surface of the thorax was shaved and the superficial musculature was exposed by 
means of a transverse incision through the skin distal to the thoracic cavity. After midline 
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laparotomy and perforation of the heart, the aorta was isolated and the in situ length taken 
as the distance from the subclavian artery to the diaphragm. Aortas were removed from 
the left ventricle to the renal arch and placed in Krebs-Ringer bicarbonate buffer (KRB) 
maintained at 37°C. 
Isolated aortas were cleaned of connective tissue, transected at the subclavian 
artery and the diaphragmatic insertion, and secured with silk suture onto polystyrene 
tubing (outside diameter 3.0 mm; inner diameter 2.6 mm) with the aid of a dissection 
microscope.  After mounting, all micro vessels were cauterized to prevent leakage and 
vessel length was adjusted with the aid of a micromanipulator to coincide to the in situ 
resting length.  All dissection and mounting procedures were performed rapidly and with 
care to prevent stretching or tearing of the aorta with the vessels incubated in oxygenated 
(95 O2:5 CO2) KRB maintained at 37ºC throughout the procedure.  After mounting, 
aortas were allowed to equilibrate in the vessel chamber for at least 1 hr. before the 
pressure loading experiment.  To examine the effect of increased loading on aortic signal 
transduction, mounted vessels were subjected to 200 mm Hg of pressure for 15 min. This 
pressure was selected based on a previous report detailing an increase in c-fos expression 
following loading at “hypertensive levels” (204 ±5 mm Hg) (87) and to minimize the 
effect of potential differences in vessel compliance.  To minimize the possibility of 
hypoxia in thickened vessels, the aortae were perfused with oxygenated (95% O2, 5% 
CO2) KRB maintained at 37º C during the incubation, using a peristaltic pump with the 
flow rate set at 11.1 ml/min., resulting in a shear stress of ~0.5 dynes/cm2.  The 
intraluminal pressure was controlled by adjusting the air pressure introduced into a fluid 
reservoir (Fig 3-1A).  The system was calibrated before all experiments.  System pressure 
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was monitored using pressure transducers (Gould model P23ID) situated before entry 
into and exit from the mounted vessel.  During the loading procedure, the pressure in 
vessels was raised in a stepwise fashion (10 mm Hg / min) to a mean arterial pressure of 
200 mm Hg which was then maintained for an additional 15 minutes.  Control vessels 
were pressurized just to the point where pressure was recorded (zero pressure) and 
maintained at this condition for 35 minutes.  Vessel diameter was obtained by the aid of a 
video camera (Logitech Quick Cam Pro 4000) mounted on an adjustable stand.  External 
vessel diameter in µm was determined from still video images using Adobe Photoshop 
and a calibrated computer software program (Measure it Right, Ver. 1.0).  Twenty-four (6 
pre-, 6 post-pressurization and 12 during pressurization) still images were taken for each 
experiment.  The mean of four width measurements, taken perpendicular to the long axis 
of the vessel, was obtained from each still frame to calculate vessel distention with 
increased loading.   
 
Western Blot Analysis 
At the end of each experiment, two segments were cut from each vessel for 
biochemical and histological analysis, and immediately snap-frozen in liquid nitrogen.  
Samples were homogenized and suspended in 100 µl of RIPA buffer (50 mM Tris, 150 
mM NaCl, 1% NP-40, 0.25% Na-deoxycholate, 1 mM EDTA, 1 µg/ml aprotinin, 1 µg/ml 
leupeptin, 1 µg/ml pepsatin, 1 mM PMSF,1 mM Na3VO4,1 mM NaF).  Samples were 
incubated on ice for 15 minutes and centrifuged at 4ºC for 5 min at 150x g to pellet 
insoluble material.  Protein concentrations of the supernate were determined in triplicate 
using BSA as a standard and the Bradford method (Pierce, Rockford, IL).  Samples were 
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diluted to a concentration of 3mg/ml in SDS-loading buffer and after boiling for 5 
minutes, 30 µg of total protein for each sample was separated on a 10% SDS-PAGE gel.  
Western blot transfer of protein onto nitrocellulose membranes was performed using 
standard conditions. (117, 126-128)  To verify transfer of proteins and equal loading of 
lanes the membranes were stained with Ponceau S.  For immunodetection, membranes 
were blocked in 5% Milk TBST for 1 hour at room temperature and then incubated with 
the appropriate primary antibody overnight.  After washing in TBST, the membranes 
were exposed to horseradish peroxidase-labeled IgG secondary antibody for 1 hour at 
room temperature.  Protein bands were visualized with ECL (Amersham Biosciences).  
Exposure time was adjusted to keep the integrated optical densities (IODs) within a linear 
and nonsaturated range, and band signal intensity was quantified by densitometry using a 
flatbed scanner (Epson Pefection 3200 PHOTO) and Imaging software (AlphaEaseFC).  
Molecular weight markers (Cell Signaling) were used as molecular mass standards and 
NIH 3T3 cell lysates were included as positive controls. A total of three SDS-PAGE gels 
were run for each experimental set to evaluate; MAPK tissue content, basal 
phosphorylation, and stretch-induced phosphorylation.  In order to obtain direct 
comparisons between expression and phosphorylation levels of different signaling 
molecules, immunoblots were stripped with Restore western blot stripping buffer as 
detailed by the manufacturer. After verifying the absence of residual HRP activity by 
reacting the membrane with the ECL reagent, membranes were washed and reprobed.  To 
minimize potential experimental error associated with membrane stripping, the order of 
immunostaining was randomized between experiments. 
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Histology and Morphometry 
 Aortic specimens were serially sectioned (8 µm) using an IEC Minotome cryostat 
and collected on poly-lysine coated slides.  After fixing in acetone, (-20°C for 2 min) 
sections were stained with hematoxylin and eosin, mounted and cover slipped.  
Morphometric evaluation was performed with the use of a computerized imaging analysis 
system (Olympus MicroSuite™ Basic).  Medial thickness in µm was calculated from the 
average of eight different points of cross section. 
 
Data Analysis 
Results are presented as mean ± SEM.  Multiple group comparisons were 
performed by one-way ANOVA followed by Student’s t-test where appropriate.  
Regression analysis of the relationship between MAPK expression or basal 
phosphorylation levels and tunica media thickness was performed across age groups 
using values from four individual aortae from each group.  Significance of correlation 
was analyzed by one-way ANOVA.  For all comparisons, the alpha level was set at P ≤ 
0.05 outside of age groups, and P≤ 0.01 for within-group analysis.   
 
Results 
Verification of loading stimulus 
During the isolated vessel experiments, the isolated vessels responded to 
incremental increases in pressure in a passive manner.  To examine if the loading 
stimulus was constant throughout the loading procedure, we constantly recorded system 
pressure before entry into and exit from the mounted aorta (Fig 3-1B).  If fluctuations in 
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loading pressure occurred, the vessel was immediately discarded.  At 200 mm Hg 
intraluminal pressure, the aortic diameter of the 6- , 30- and 36-month old animals 
increased 44.6 %, 67.0 %, and 61.1 %, respectively. 
 
Aging effects on aortic pressure and wall morphology 
 No evidence of age-associated pathology was observed in any of the cross 
sections (Fig 3-2).  Compared to the 6 month old animals, aging increased the tunica 
media thickness of the aorta ~11.2% and 21.1% at 30- and 36-months, respectively 
(P<0.01) (Fig 3-2B).  Systolic blood pressure was not significantly different among the 
three age groups (Table 3-1).  Body weights of aged and very aged rats were not 
significantly different but were increased compared to 6 month values. 
 
Aging effects on MAPK expression and phosphorylation 
To explore whether aging influenced the total amount of ERK 1/2, p38 and JNK 
MAPK present in the aorta, gel electrophoresis and Western blot analysis were performed 
using antibodies which recognize both the unphosphorylated and phosphorylated forms 
of the proteins. Western blot analysis failed to demonstrate any changes in the expression 
of the ERK1/2 MAPK with aging (Fig. 3-3, Table 3-2).  However, in the 30-month 
aortas, total p38 MAPK and JNK MAPK expression increased 83.4% and 81.4%, 
respectively (P<0.01).  Compared to 6-month aortas, total JNK MAPK expression in 36 
month aortas increased 72.3% (P<0.01).   
Because the MAPK proteins are activated by phosphorylation it was important to 
determine if aging in the aorta was characterized by changes in the basal level of MAPK 
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protein phosphorylation.  Similar to our analysis of the total MAPK expression, it 
appeared that the phosphorylation status of the MAPK proteins was also regulated 
differently with aging.  Compared to 6-month aortae, basal phosphorylation of the ERK 
1/2 MAPK decreased 31.3% and 26.2% at 30- and 36-months, respectively (P<0.01) 
(Fig. 3-4, Table 3-2).  In contrast, the phosphorylation of the p38 MAPK increased 
128.7% at 30-months and 97.0% at 36-months (P<0.01) (Fig. 3-5, Table 3-2).  In a 
similar fashion, the phosphorylation of the JNK MAPK increased with aging 23.9% and 
14.5 % at 30- and 36-months, respectively (Fig. 3-6, Table 3-2).  Regression analysis 
indicated significant correlation between the tissue content of JNK, the phosphorylation 
levels of ERK 1/2 and p38 and the thickness of the tunica media (Table 3-4). 
 
Aging effects on MAPK phosphorylation in response to intraluminal pressure 
 
 In parallel studies, the effect of pressurization of aortae on ERK 1/2, p38 and JNK 
MAPK phosphorylation was determined.  In aortae subjected to 15 minutes of pressure 
loading (200 mm Hg), phosphorylation of the ERK1/2 MAPK increased 27%, 73%, and 
42 % for the 6-, 30-, and 36-month age groups, respectively (P<0.05) (Fig. 3-4, Table 3-
3).  In a similar fashion, pressure loading increased p38 MAPK phosphorylation in the 6-, 
30-, and 36-month aortas by 320.2%, 98.55, and 45.7%, respectively (P<0.05) (Fig. 3-5, 
Table 3-3).  Increased JNK MAPK phosphorylation of 51.2% and 21.4% with pressure 
loading was found in the 6- and 30- month aortas (P<0.05).  However, pressure loading 
failed to increase JNK MAPK phosphorylation in the 36-month old aortas (Fig. 3-6, 
Table 3-3). 
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Discussion 
Arteries are capable of structural and functional changes in response to alterations 
within their milieu or to changes in hemodynamic variables.  Vascular remodeling may 
be considered as an adaptive process in response to long-lasting changes in arterial blood 
flow and/or pressure, in which the ultimate effect tends to be maintenance of the 
constancy of tensile and/or shear stresses.  Similar to previous reports (27, 33, 37), tunica 
media thickness was found to significantly increase with age.  This age-associated 
increase in aorta media thickness is thought to occur via smooth muscle cell hypertrophy. 
(120, 121)  Both human and animal studies have demonstrated that hypertension, if not 
controlled, can cause wall thickening (15, 30)and it is thought that this wall hypertrophy 
in turn acts to normalize wall tension.  The exact mechanism(s) underlying hypertension-
associated remodeling are not known; however, an elevation in blood pressure will cause 
an increase in the amount of tension experienced by vascular smooth muscle cells 
(VSMC) residing in the vessel wall.  It has been demonstrated that stretch is an important 
hypertrophic stimulus for both smooth and striated (cardiac and skeletal) muscle.  Indeed, 
a number of in vitro studies using VSMC cultured on deformable substrates have 
demonstrated that direct mechanical loading of the cell is capable of inducing cell 
growth.(60, 76)  A previous report has indicated systolic blood pressure is increased in 
30- vs. 6-month old F1 hybrid rats.(80)  However, our results show no age-associated 
elevation of blood pressure in these animals, suggesting the described changes in vessel 
morphology is not a result of hypertensive stimuli. 
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A major finding of the present study is that when normalized based on total 
protein, MAPK concentrations and basal levels of phosphorylation appear to be regulated 
differently with aging in the rat aorta.  For example, total ERK 1/2 MAPK content 
remains constant with age, while p38 MAPK levels are increased at 30 months, and JNK 
MAPK is elevated at both 30- and 36-months.  To our knowledge, age-associated change 
in the concentration of these molecules has not been reported before in vascular smooth 
muscle.  However, similar to our findings in rat smooth muscle, Williamson et al. (139) 
found ERK 1/2 MAPK expression levels were unchanged with aging in the skeletal 
muscle of humans.  The physiological impact of increased p38 and JNK MAPK 
expression in vascular smooth muscle with aging is unknown.  However, these kinases 
are both characterized as stress-activated proteins.(9)  Given our finding of normotensive 
blood pressure in aged F1 hybrid rats, the results suggest the vessel hypertrophy seen in 
these animals is due to regulatory dysfunction not directly related to changes in pressure 
and hemodynamic conditions.  Our finding of an increased basal activation of p38 and 
JNK MAPK family members with aging (Table 3-2) is consistent with significant 
alteration in regulatory function.  One possibility is that increased basal MAPK activation 
in aged rats could result from non-mechanical stimuli (7) including; H2O2, reactive 
oxygen species, cytokines, inflammation, angiotensin II, endothelin-1, and receptor 
tyrosine kinases (insulin-like growth factor, transforming growth factor-β, and fibroblast 
growth factor). (8, 44, 45, 64, 75)  Previous investigations have demonstrated an 
increased H2O2 production in the aorta from older animals which is not surprising in light 
of the general increase in reactive oxygen species in other tissues with aging. (124)  
Finally, increased basal p38 and JNK MAPK expression may be causally linked to 
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increases in tunica media thickening.  Indeed, a number of studies have found that these 
two MAPK family members are required for cardiac hypertrophy. (102)  However, only 
JNK expression showed significant correlation with medical thickness in the present 
study (Table 3-4).  Conversely, the lack of an increase in ERK1/2 expression with aging 
and poor correlation of the expression of this protein with medial thickness may suggest 
that this MAPK is not directly involved in smooth muscle cell hypertrophy.  In any case, 
our results clearly indicated changes in MAPK protein expression and signaling with 
aging suggesting exaggerated basal activity in at least two pathways.  Further information 
on the individual or combined effects of these changes in tissue content and activity of 
the MAPKs on downstream signaling may reveal their overall impact on VSMC status. 
A novel finding is that activation (phosphorylation) of p38 and JNK MAPK 
proteins in response to acute mechanical stress is blunted while ERK1/2 is enhanced in 
aortae from aged animals.  The smooth muscle cells of the vasculature are constantly 
exposed to mechanical strain from superimposed pulsatile and mean pressure loads by the 
cardiac contractile cycle in vivo.  It is thought that this mechanical strain modulates 
cellular orientation, synthesis of extracellular matrix, myosin isoform expression, and 
cellular proliferation. (60, 76, 84, 87)   Although the cellular mechanism by which 
mechanical strain stimulates VSMC growth remains obscure, recent in vitro studies have 
focused on the potential involvement of MAPK family members in the long-term 
responses including cell proliferation, apoptosis and differentiation. (102)  In this study, 
we measured pressure-induced phosphorylation of the ERK 1/2, p38, and JNK MAPKs in 
freshly isolated aortae from animals of different ages.  Similar to results from previous in 
vivo studies using acute hypertension (75, 146)and balloon-overstretched injury (61)in 
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young adult animals, we demonstrate activation (phosphorylation) of the MAPK cascade 
in adult (6-month) vessels.  We further demonstrate an increased ERK 1/2 MAPK 
activation and reduced p38 and JNK MAPK activation with increasing age which, to our 
knowledge, has not been previously reported in vascular tissue.  Our findings of 
decreased p38 and JNK MAPK phosphorylation in the aorta in response to mechanical 
stimuli are similar to results others have reported using mitogenic activation in other cell 
and tissue types. (61, 77, 78, 100, 137)  Gennanro and colleagues (30) recently noted one 
exception to this trend.  These researchers used VSMC isolated from the aorta of young 
and old rabbits and, similar to the present study, demonstrated an increased degree of 
ERK 1/2 MAPK phosphorylation following serum stimulation of aged cells.  Their 
findings, like ours, suggest that VSMC cells are different from a variety of cell types 
which have all been shown to be characterized by reductions in ERK 1/2 MAPK 
activation with aging.  Why aging in VSMC may be associated with an increased ability 
to activate the ERK 1/2 MAPK is not known.  However, it is possible that augmented 
ERK 1/2 MAPK activity in response to cellular insult may be advantageous in protecting 
aged cells from apoptosis, or perhaps play a role in the enhanced cellular proliferation 
and neointimal formation seen in aged vascular tissues subsequent to wall injury. (121)  
Because most of our knowledge concerning the regulation and function of MAPK has 
resulted from studies on cultured cells, little is known about their activation in vivo.  
However, in adult tissues, the mechanisms regulating ERK1/2, p38, and JNK MAPK 
activation by mechanical stress have been linked to stretch-induced release of angiotensin 
II, phenylephrine, and endothelin-1 in cardiac myocytes, and PDGF, fibroblast growth 
factor, and ATP in VSMC. (8, 20, 44, 45, 64, 75)  It is thought that many of these factors 
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may activate MAPK family members in an autocrine and/or paracrine manner.  The 
presence of such events cannot be excluded in the present study.  However, previous 
investigations showed that cultured VSMC exposed to the conditioned media collected 
from VSMC after stretching failed to produce increases in ERK1/2 MAPK 
phosphorylation suggesting that the release of these factors does not play a significant 
role in vascular smooth muscle.(120)  Other studies investigating MAPK activation with 
mechanical load have proposed that signaling pathways converging at nonreceptor 
tyrosine kinases may play a role. (64)  Whether two prototypical members of this family, 
proline-rich tyrosine kinase 2 or focal adhesion kinase participate in pressure-induced 
ERK 1/2 activation is at present being intensely investigated in our laboratory.    
We feel that one strength of the present investigation was our use of intact vessels 
for loading experiments.  As such, our preparations included both a smooth muscle and 
endothelial layer thus mimicking in vivo conditions as closely as possible.  Hence, the 
possibility exists that non-vascular smooth muscle tissue contributed to results.  Previous 
investigations utilizing differentiated vascular tissues have demonstrated that activated 
MAPK family members are found in the vascular smooth muscle cells (141, 146) and we 
consider it unlikely that endothelial cells, which comprise less than 5% of the artery cell 
population, accounted for a significant proportion of the response we observe.  
Nonetheless, such an issue in our preparations and in animals of different ages requires 
further investigation.  
In summary, we have demonstrated the in vitro activation of ERK1/2, p38 and 
JNK in the arteries of rats following an acute elevation in loading pressure.  Protracted 
loading, such as that induced by hypertension or the cellular response subsequent to 
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injury, is characterized by the growth and proliferation of smooth muscle cells.  That 
MAPK activation occurs with increases in pressure suggests an important role for these 
kinases in the arterial adaptation to fluctuations in blood pressure. Our findings provide 
evidence for the possibility that MAPK activation may also contribute directly to age-
associated alterations in aortic vessel remodeling. 
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Figures and Legends  
Table 3-1 
 Body weight and systolic blood pressure of young adult (6 month), aged (30 month), 
and very aged (36 month) Fischer 344/Brown Norway F1 hybrid rats. 
 
 
 
 
Group 
 
N 
 
Body Weight, g
 
Systolic BP, mmHg 
    
6 month 6 421 ± 17 143 ± 3 
 
30 month 6 549 ± 22 131 ± 8 
 
36 month 6 482 ± 28 135 ± 4 
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Table 3-2  
Tissue concentration and basal levels of phosphorylated MAPKs in aortae excised 
from young adult (6 month), aged (30 month) and very aged (36 month) Fischer 344X 
Brown Norway F1 rats.  Results were obtained by Western blot analysis using antibodies 
which recognized the unphosphorylated and phosphorylated forms of the proteins.  Data 
are presented as percent of the young adult value.  An (n.s.) indicates the value was not 
significantly different from the young adult. 
 
 
 6 mo.  
basal level 
30 mo.  
basal level 
36 mo.  
basal level 
    
ERK1/2 100.0 ± 6.3 n.s. n.s. 
p-ERK1/2 100.0 ± 1.1   68.7 ± 2.4   73.8 ± 6.3 
    
p38 100.0 ± 7.9   183.4 ± 17.6 n.s. 
p-p38 100.0 ± 3.2 228.7 ± 2.6   197.0 ± 13.6 
    
JNK   100.0 ± 23.2 181.3 ± 9.5 172.3 ± 3.8 
p-JNK 100.0 ± 2.9 123.9 ± 4.1 114.5 ± 1.6 
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Table 3-3 
 Pressure-induced, percent change in phosphorylation of MAPKs in aortae 
obtained from young adult (6 month), aged (30 month), and very aged (36 month) Fischer 
344X Brown Norway F1 rats.  Values were obtained by Western analysis utilizing 
antibodies that recognized the phosphorylated forms of the proteins.  An asterisk (*) 
indicates a significant difference from the 6 month value, p < 0.05. 
 
 
 
 6 mo. 30 mo 36 mo 
    
p-ERK1/2 +27.0 ± 1.8   +50.3 ± 11.6* +30.6 ± 17.3 
    
p-p38 +320.0 ± 12.2 +225.1 ± 17.6*   +89.9 ± 22.7* 
    
p-JNK +51.2 ± 4.3 +26.5 ± 5.0*  -17.0 ± 2.5* 
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Table 3-4 
 Regression analysis of the relationship between basal levels of expression and 
phosphorylation of ERK 1/2, p38, and JNK MAPKs and the thickness of the tunica media 
of aortae obtained young adult (6 month), aged (30 month), and very aged (36 month) 
Fischer 344/Brown Norway F1 hybrid rats.  The results reflect the analysis of combined 
MAPK and thickness comparisons of four individual aortas from each age group.  An 
asterisk (*) indicates significant correlation between parameters, p < 0.01 or greater. 
 
Total Tissue Content R 
  
ERK 1/2 0.005 
P38 0.011 
JNK   0.522* 
  
  
Percent Phosphorylation  
  
ERK 1/2   0.628* 
P38   0.572* 
JNK 0.383 
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Figure 3-3 
A.     
 
B.
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Figure3-1.  A: Schematic of experimental setup.  A reservoir positioned upstream of 
the peristaltic pump maintained perfusate and was temperature controlled. A second fluid 
reservoir served as a hydraulic mechanism for increasing pressure in the system.  A 
sphygmometer bulb (Welch Allyn) was used to pressurize the system.  Two inline 
transducers measured pre- and post-aortic pressure levels.  A force transducer (PCB, 
Piezoelectronics) located on an adjustable micrometer measured the force experienced by 
the vessel perpendicular to the flow of the system. Vessel intraluminal pressure was 
controlled by adjusting the air pressure introduced into the fluid reservoir.  System 
calibration was performed before all experiments.  B: Representative pressure-time 
tracing of aortic loading.  Tracing obtained from force transducer positioned proximal 
to aortic vessel.  Note the consistency of pressure maintenance over the interval of 
experimentation. 
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Figure 3-4  
A. 
 
 
 
B. 
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Figure 3-2.  Morphometric changes in the aortic wall of young adult (6 month), aged 
(30 month) and very aged (36 month) rats.  A) Sections stained with hematoxylin and 
eosin demonstrate the progressive thickening of the medial layer of the aortic wall with 
aging.  Bar indicates 100 :m.  B) Bar graph indicating significant increases (*) in the 
thickness of the tunica media of aortae from aged and very aged rats compared to young 
adult animals.  Thickness was measured from serial cross-sections of each vessel with 
data averaged from eight different points of cross-section. 
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Figure 3-5 
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Figure 3-3. Aging differentially affects MAPK protein expression. Aortic segments 
from young adult (6 month), aged (30 month), and very aged (36 month) rats were 
analyzed by Western analysis for age-related changes in total ERK 1/2, p38, and JNK 
MAPK protein expression.  Results are expressed as percent of the 6 month value.  An 
asterisk (*) indicates significant difference from the young adult (6 month) value, p < 
0.05 or greater.  
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Figure 3-6 
 
 
Figure 3-4.  Effects of aortic pressurization on phosphorylation of ERK 1/2 MAPK.  
Aortae were removed from 6, 30 and 36-month old animals, cannulated and pressurized 
to 200 mm Hg for 15 minutes.  ERK 1/2 MAPK phosphorylation was determined by 
Western analysis and immunodetection for ERK 1/2 MAPK phosphorylated on Thr 202 
and Tyr 204 (phospho-ERK 1/2 MAPK).  Phosphorylation status was calculated as 
phospho-specific optical density divided by the 6 month value.  An asterisk (*) or (+) 
indicates significant difference from the non-pressurized control of that group or the 
corresponding 6 month value, respectively, p < 0.01, n = 4 observations for each group. 
Kevin M. Rice Page 53 4/22/2005  
Figure 3-7 
 
 
Figure 3-5.  Effects of aortic pressurization on phosphorylation of p38 MAPK.  
Aortae obtained from 6, 30, and 36 month old rats were cannulated and pressurized to 
200 mm Hg.  p38 MAPK phosphorylation was determined by Western analysis and 
immunodetection for p38  MAPK phosphorylated on Thr 180 and Tyr 182 (phospho- p38α 
MAPK).  Phosphorylation status was calculated as phospho-specific optical density 
divided by the 6 month value.  An asterisk (*) or (+) indicates a significant difference 
from the non-pressurized control of that age group or the corresponding 6 month value, 
respectively, p < 0.01, n = 4 observations per group.  
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Figure 3-8 
 
 
Figure 3-6.  Effects of aortic pressurization on JNK MAPK phosphorylation.  Aortae 
obtained from 6, 30, and 36-month old rats were cannulated and pressurized to 200 mm 
Hg.  JNK MAPK phosphorylation was determined by Western analysis and 
immunodetection for JNK MAPK phosphorylated on Thr183 and Tyr185 (phospho-JNK 
MAPK).  Phosphorylation status was calculated as phospho-specific optical density 
divided by the 6 month value.  An asterisk (*) or (+) indicates a significant difference 
from the non-pressurized control of that age group or the corresponding 6 month value, 
respectively, p < 0.01, n = 4 observations for each group. 
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Chapter 4 
CONCLUSIONS 
1. Aging was found to significantly alter basal expression of p38 and JNK in the 
30 month animals, how ever on JNK remained scientifically altered in the 36 
month aortas. 
 
2. Aging was found to significantly alter the basal phosphorylation of ERK 1/2, 
p38, and JNK. 
 
3. Aging was found to alter pressure induced signaling in the aortas. ERK 1/2, 
and p38 pressure induced phosphorylation was slightly diminished with age. 
However pressure induced JNK phosphorylation was lost in the very aged 
animals.      
 
4. We observed age associated increase in tunica medial thickness similar to age-
associated vascular structure seen in humans, these data support the utility of 
the F1 strain as a tool to investigate the age associated alterations 
cardiovascular seen in aging humans.   
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Further directions  
 Future directions for research based on this study should focus on the mechanisms 
associated with the differences in load induced MAPK activation with aging in the 
F344BN aorta.   
MAPK activation is a complex process necessitating the integration of many 
different participants.  The mechanisms associated with differences in MAPK activation 
with aging may lie in differences in aortic wall structure.  A study designed to determine 
how mechanical properties are altered with age may be invaluable to understanding age-
associated changes in aortic mechanotransduction.  This study could be done by 
subjecting aortas from different aged animals to increased pressure and examining the 
physical response.  Alterations in compliance, contractile response, K+ sensitivity, and 
numerous other factors could be examined to address age related alterations. Conversely 
endothelia damage has been associated with many pathological conditions with aging, in 
addressing the above mentioned mechanical properties of the aortic tissue the removal of 
the endothelium may shine light on the age related loss or damage of this tissue layer. 
Overall many age-associated changes involving mechano-sensing, mechano-stimulation, 
mechano-transduction, and force perception have not been addressed. If age alters the 
tissues ability to perceive and respond to mechanical stimuli, knowing if these alteration 
are due to changes in tissue structure and architecture or in proteins associated with 
specific signaling pathways may provide an avenue to inhibit age-associated changes in 
mechanotrasduction. 
 Although the effects of mechanical stress could be mediated in part, by activation 
of mechanosensitive ion channels or by locally and systemically released growth factors,  
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the seminal studies of Ingber and others (50-57) have demonstrated that mechanical input 
itself is able to trigger cellular signaling mechanisms.  Increasing evidence supports the 
notion that living cells transduce and transmit forces into biochemical signals through 
specialized focal sites of the membrane known as focal adhesion complexes.  These 
regions are rich in a variety of signaling molecules including focal adhesion kinase 
(FAK), RhoA, c-Src family kinases, paxillin, cdc42, Rac1, Ras family proteins, 
phosphatidylinositol 3-kinase (PI3-K), PKC, and MAPK.  It is thought that these 
signaling molecules may act as the “transducers” of mechanical stimuli that integrin 
dependent signals use to regulate alterations in gene transcription and translation (1, 86, 
109).  To investigate the possibility that age-associated alterations in FAK signaling may 
be involved in the different MAPK phosphorylation we see with aging, we could 
compare resting levels and the phosphorylation (activation) of the FAK signaling 
pathway after increases in intraluminal pressure in isolated aortae from different age 
groups of F344XBN rats.   
Alternatively, another potent activator of MAPK phosphorylation may be reactive 
oxygen species (ROS). Defined as an imbalance between the generation of ROS and the 
existing antioxidative defense mechanisms, oxidative stress has been implicated to play 
important roles in tissue injury, vascular remodeling, apoptosis, and aging.  Recent 
investigations have identified that oxidative stress is capable of activating MAPK 
proteins (5, 6, 108).  To investigate whether alterations in ROS contribute to age-
associated differences in MAPK signaling we could repeat the experiments performed in 
this study in the absence and presence of ROS scavengers.  A similar MAPK response to 
increased intraluminal pressure in the presence of ROS scavengers with aging would 
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suggest that ROS are not factor involved in age associated changes of pressure induced 
MAPK activation. Conversely,  if introduction of ROS in the 6-month animals altered 
MAPK pathway activation to resemble that of the 36-month age group, we could 
postulate that age related increase in ROS alter the pressure induced activation of 
MAPKs pathway related proteins. 
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Appendix A 
Subsection A (Pressure traces) 
Preliminary Pressurization Experiments 
The following is the preliminary pressurization experiments performed to test the 
validity of our project design. 
Figure A -9 
 
 
 
Figure  
Preliminary experiment on 3-11-2004, this represents a 6-month-old F1 male rat 
aorta pressurized for 15 min at 200mm hg.  
 
Figure A - 10 
 
Figure  
Preliminary experiment on 3-11-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 5 min at 200mm hg.  
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Figure A - 11 
 
 
 
 
Figure  
Preliminary experiment on 3-16-2004, this represents a 6-month-old F1 male 
rat aorta pressurized for 15 min at 200mm hg.  
Figure A - 12  
Figure  
Preliminary experiment on 3-22-2004, 
this represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
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6 Month Pressure Experiments 
 The following represent the graphical output of the force-transducers for the 
designated experiment. 
 
 15 Minute Pressure Experiment 
Figure A - 13 
 
Figure  
Experiment on 5-11-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
 
 
Figure A - 14 
 
Figure  
Experiment on 5-11-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
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Figure A - 15 
Figure  
Experiment on 4-5-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
 
 
Figure A - 16 
 
Figure  
Experiment on 5-25-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
 
 
 
 
Figure A - 17 
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Figure  
Experiment on 5-26-2004, this 
represents a 6-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
 
 
30 Month Pressure Experiments 
  
 15 Minute Pressure Experiment 
Figure A - 18 
 
 
 
Figure  
Experiment on 5-7-04, this represents a 30-month-old F1 male rat aorta 
pressurized for 15 min at 200mm hg.  
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Figure A - 19 
 
Figure  
Experiment on 5-10-04, this represents 
a 30-month-old F1 male rat aorta pressurized 
for 15 min at 200mm hg.  
 
Figure A - 20 
 
Figure  
Experiment on 5-27-04, this represents 
a 30-month-old F1 male rat aorta pressurized 
for 15 min at 200mm hg.  
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Figure A - 21 
 
Figure  
Experiment on 5-28-04, this represents 
a 30-month-old F1 male rat aorta pressurized 
for 15 min at 200mm hg.  
 
Figure A - 22 
 
Figure  
Experiment on 6-3-04, this represents a 
30-month-old F1 male rat aorta pressurized for 
15 min at 200mm hg.  
 
 
Kevin M. Rice Page 87 4/22/2005  
36 Month Pressure Experiments 
 15 Minute Pressure Experiment 
Figure A - 23 
 
Figure  
Experiment on 4-14-2004, this represents a 36-
month-old F1 male rat aorta pressurized for 15 min at 
200mm hg.  
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Figure A - 24 
 
Figure  
Experiment on 5-25-2004, this represents a 36-
month-old F1 male rat aorta pressurized for 15 min at 
200mm hg.  
 
Figure A - 25 
 
Figure  
Experiment on 5-27-2004, this represents a 36-
month-old F1 male rat aorta pressurized for 15 min at 
200mm hg.  
 
Figure A - 26 
 
Figure  
Experiment on 5-28-2004, this represents a 36-
month-old F1 male rat aorta pressurized for 15 min at 
200mm hg.  
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Appendix B 
Film interpretation 
 Working guidelines: 
1. Shoot for a film exposure that gives “scan worthy” bands when the 
exposure is > 1 min.  The longer the exposure, the better, because this 
suggests that the slope of the enzyme reaction rate line is < 1.0. 
 
2. Examine the bands- is any one of them “saturated”?  If so, this film 
cannot be used without justification. 
 
 
3. Examine the background- is it “excessive”?  Does it compromise the 
interpretation?  If so, this film cannot be used without justification. 
 
4. Examine the band shape present in each and all lanes.  “A band should 
be a band” and it should “look like a band” e.g. a line.  Not a “blob”, 
“smudge”, “or something else. 
 
 
5. Refer to “Figure worthy” data point criteria before proceeding further. 
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“Figure worthy” data point 
Definition:  
1. If using a pooled sample (minimum n=3 separate samples), each 
sample must be run on a minimum of 3 lanes (preferably ≥ 4).  Take 
this mean value (IDV or area or some other assessment) and find the 
mean value.   
 
2. If this mean value, when subjected to statistical analysis, does not 
“work” then data point must be re-done. 
 
3. * A “lane” or “gel” cannot be displaced without adherence to sampling 
assumptions. 
 
In an ideal situation, each and every antibody should have standard conditions for 
dilution, blocking, washes, exposures etc.  It is recommended to start with the 
manufactures’ protocol as an initial starting point.  Everyone’s input is encouraged 
and expected.   
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Subsection A (Film Reports) 
 The following are the film reports will immunoblot films, for the appropriate 
protein molecule.  
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JNK  
Film Properties Report JNK (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: JNK (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 5% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 46, 54 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
Kevin M. Rice Page 93 4/22/2005  
Film Properties Report JNK (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: JNK (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 5% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 46, 54 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-JNK (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: p-JNK (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 5% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 46, 54 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-JNK (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: p-JNK (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 5% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 46, 54 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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P38  
Film Properties Report p38 (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody:  p38 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 38 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p38 (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody:  p38 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight:  38 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-p38 (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody:  p-p38 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 2°C   Medium: 10% BSA  
Secondary Antibody: Anti Mouse     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 38 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-p38 (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody:  p-p38 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Mouse     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight:  38 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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P44/42 MAPK (ERK 1/2)   
Film Properties Report ERK1/2 (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: ERK 1/2 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 42, 44 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report ERK1/2 (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: ERK 1/2 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Rabbit     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 42, 44 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-ERK1/2 (1) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: p-ERK 1/2 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Mouse     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 42, 44 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Film Properties Report p-ERK1/2 (2) 
Experimenter: Kevin M. Rice   
Muscle / Tissue:  Aorta    Species: F1 rat F344 X BN 
Protein concentration: 30 µg/ml   Gel type: 10% Tris-HCL SDS-PAGE 
Electrophoresis Voltage: 120V Transfer Voltage: 24V  Duration: 45 min   
Primary Antibody: p-ERK 1/2 (Cell Signaling) Primary Antibody Dilution: 1/500 
Incubation Time: overnight @ 4°C   Medium: 10% BSA  
Secondary Antibody: Anti Mouse     Secondary Antibody Dilution: 1/1000 
Incubation Time: 1hr @ room temp  Medium: 1% milk in TBS-T 
Exposure Time 1 min    Molecular weight: 42, 44 kDa 
Lane 1: Hela Cell Extract 3 µl  
Lane 2: NIH 3T3 Activated Cell Extract 3 µl 
Lane 3: L6 IGF Cell Extract 3 µl 
Lane 4: Rainbow Marker RPN756 3 µl 
Lane 5: 6 month control 20 µl 
Lane 6: 6 month 15 min pressure 20µl 
Lane 7: 30 month control 20 µl 
Lane 8: 30 month 15 min pressure 20 µl  
Lane 9: 36 month control 20 µl 
Lane 10: 36 month 15 min pressure 20 µl 
Lane 11: Rainbow Marker RPN756 3 µl 
Lane 12: Biotinylated Ladder 3 µl  
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Subsection B (Raw data) 
This section represents the raw data tables Produced from spot densitometry of 
the immunoblot films.  
 
JNK Data Set  
Total JNK IDV values 
 6 Control 6 Press 30 Control 30 Press 36 Control 36 Press 
IDV 689472 756000 883008 731808 719712 743904
IDV 187488 338688 683424 725760 798336 562464
IDV 696348 756378 906453 726363 714357 750375
IDV 186093 342171 696348 738369 792396 552276
IDV 692208 752928 916872 728640 722568 765072
IDV 188232 346104 704352 734712 807576 552552
IDV 702032 750448 907800 726240 720188 756500
IDV 188232 346104 704352 734712 807576 552552
       
N 8 8 8 8 8 8
Mean 441263.1 548602.6 800326.13 730825.5 760338.63 654461.9
Standard 
Deviation 271296.6 219533.4 110926.23 4772.77817 44300.5 106584.9
Standard 
Error of the 
mean 102540.5 82975.81 41926.175 1803.94058 16744.015 40285.31
       
 6   Control 6 Pressure 30 Control 
30 
Pressure 36 Control 
36 
Pressure 
Relative 
Expression 
Level 1 1.243255 1.8137163 1.65621249 1.7230958 1.483156
Standard 
error of the 
mean 0.232379 0.188042 0.095014 0.00408813 0.0379456 0.091295
 
 
Kevin M. Rice Page 105 4/22/2005  
  
 
Phosphorylated JNK  IDV Values 
 6 Control 6 Press 
30 
Control 30 Press 
36 
Control 36 Press 
IDV 981558 1399629 1260272 1375393 999735 896732
IDV 805847 1314803 945204 1308744 1054266 830083
IDV 990000 1392000 1230000 1356000 990000 882000
IDV 798000 1302000 960000 1314000 1080000 882000
IDV 960640 1392928 1242828 1380920 936624 906604
IDV 786524 1308872 990660 1320880 1098732 834556
IDV 1003002 1387386 1207206 1369368 984984 888888
IDV 810810 1291290 1003002 1309308 1027026 834834
       
N 16 16 16 16 16 16
Mean 892047.6 1348614 1104897 1341827 1021421 869462.1
Strandard Deviation 99018.65 48008.02 141023.8 31576.23 54108.95 31129.19
Standard Error of the 
mean 25566.51 12395.62 36412.18 8152.948 13970.87 8037.523
       
 
6   
Control 
6    
Pressure 
30 
Control 
30 
Pressure 
36 
Control 
36 
Pressure 
Relative Expression 
Level 1 1.511818 1.238607 1.50421 1.14503 0.974681
Standard error of the 
mean 0.02866 0.013896 0.040819 0.00914 0.015662 0.00901
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P38 Data Set 
Total p38 IDV values 
 6 Control 6 Press 30 Control 30 Press 36 Control 36 Press 
IDV 32256 30240 64512 52416 36288 36288
IDV 30375 30375 62775 46575 38475 36450
IDV 34510 32480 60900 50750 36540 34510
IDV 34680 32640 63240 48960 36720 36720
IDV 22176 32256 38304 58464 24192 28224
IDV 22528 32768 38912 57344 24576 26624
IDV 22880 33280 39520 58240 22880 27040
IDV 22165 32240 38285 56420 24180 26195
       
N 8 8 8 8 8 8
Mean 27696.25 32034.88 50806 53646.13 30481.38 31506.38
Standard 
Deviation 5783.498 1116.106 12925.73 4591.072 7022.009 4873.805
Standard Error 
of the mean 2185.957 421.8486 4885.466 1735.262 2654.07 1842.125
       
 6 Control 6 Pressure 30 Control 30 Pressure 36 Control 36 Pressure
Relative 
Expression 
Level 1 1.15665 1.8344 1.936945 1.10056 1.137568
Standard error 
of the mean 0.078926 0.015231 0.176394 0.062653 0.095828 0.066512
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Phosphorylated p38 IDV Values 
 6 Control 6 Press 30 Control 30 Press 
36 
Control 36 Press 
IDV 652080 797544 403200 614880 463680 491568
IDV 660240 801360 396975 608025 462300 498960
IDV 650160 796320 399424 616832 475264 493920
IDV 655200 801360 401280 616968 461472 488880
IDV 624102 816914 472350 909525 477375 842284
IDV 614880 826560 483840 897120 473760 851760
IDV 619028 821988 481650 907530 476580 842284
IDV 624960 816914 466488 897864 471504 816480
       
N 8 8 8 8 8 8
Mean 637581.3 809870 438150.9 758593 470241.9 665767
Standard 
Deviation 18488.74 11982.19 40932.86 154470 6689.944 184628.8075
Standard Error 
of the mean 6988.086 4528.844 15471.17 58384.16 2528.561 69783.12995
       
 6 Control 
6 
Pressure 30 Control 
30 
Pressure 
36 
Control 36 Pressure 
Relative 
Expression 
Level 1 1.270222 0.687208 1.189798 0.73754 1.044207307
Standard error 
of the mean 0.01096 0.007103 0.024265 0.091571 0.003966 0.109449784
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P44/42 MAPK (ERK 1/2) Data Set  
 
Total ERK 1/2 IDV values 
 6 Control 6 Press 30 Control 30 Press 36 Control 36 Press 
IDV 582552 690480 650160 645120 720720 778410
IDV 808542 821520 821520 887040 700560 778410
IDV 573249 632875 643001 627812 703757 750804
IDV 791388 774639 830332 891088 713883 776169
IDV 593541 683505 648064 653127 708820 776169
IDV 796461 830332 825269 896151 718946 776169
IDV 583395 709800 664170 648960 725010 781242
IDV 796461 821340 811200 882180 709800 776169
       
N 8 8 8 8 8 8
Mean 690698.6 745561.4 736714.5 766434.8 712687 774192.8
Standard 
Deviation 115164.8 75975.3 91606.08 131409.8 8511.24 9620.797
Standard Error of 
the mean 43528.21 28715.97 34623.84 49668.25 3216.946 3636.32
       
 6   Control 6 Pressure 30 Control 
30 
Pressure 36 Control 
36 
Pressure 
Relative 
Expression Level 1 1.079431 1.066622 1.109651 1.031835 1.120884
Standard error of 
the mean 0.063021 0.041575 0.050129 0.07191 0.004658 0.005265
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Phosphorylated ERK 1/2 IDV Values 
 6 Control 6 Press 
30 
Control 30 Press 
36 
Control 36 Press 
IDV 652080 797544 403200 614880 463680 491568
IDV 660240 801360 396975 608025 462300 498960
IDV 650160 796320 399424 616832 475264 493920
IDV 655200 801360 401280 616968 461472 488880
IDV 624102 816914 472350 909525 477375 842284
IDV 614880 826560 483840 897120 473760 851760
IDV 619028 821988 481650 907530 476580 842284
IDV 624960 816914 466488 897864 471504 816480
       
N 8 8 8 8 8 8
Mean 637581.3 809870 438150.9 758593 470241.9 665767
Standard Deviation 18488.74 11982.19 40932.86 154470 6689.944 184628.8075
Standard Error of the 
mean 6988.086 4528.844 15471.17 58384.16 2528.561 69783.12995
       
 
6   
Control 
6    
Pressure 
30 
Control 
30 
Pressure 
36 
Control 36 Pressure 
Relative Expression 
Level 1 1.270222 0.687208 1.189798 0.73754 1.044207307
Standard error of the 
mean 0.01096 0.007103 0.024265 0.091571 0.003966 0.109449784
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Subsection C (Statistics)  
 
JNK  
One Way Analysis of Variance  
Normality Test: Passed (P > 0.050) 
Equal Variance Test: Failed (P = <0.001) 
Test execution ended by user request, ANOVA on Ranks begun 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
Group N  Missing  Median    25%      75%     
6 Control 8 0 438852.000 187860.000 694278.000  
6 Press  8 0 548276.000 344137.500 754464.000  
30 Control 8 0 793680.000 700350.000 907126.500  
30 Press 8 0 730224.000 726301.500 734712.000  
36 Control 8 0 757482.000 719950.000 802956.000  
36 Press 8 0 653184.000 552552.000 753437.500  
 
H = 15.432 with 5 degrees of freedom.  (P = 0.009) 
 
The differences in the median values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = 0.009) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
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All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method): 
 
Comparison   Diff of Ranks  q P<0.05  
36 Control vs 6 Control 186.500  4.710 Yes   
36 Control vs 6 Press  88.000   2.661 No   
36 Control vs 36 Press 72.000   2.714 Do Not Test   
36 Control vs 30 Press 32.000   1.600 Do Not Test   
36 Control vs 30 Control 5.500   0.408 Do Not Test   
30 Control vs 6 Control 181.000  5.474 Yes   
30 Control vs 6 Press  82.500   3.109 Do Not Test   
30 Control vs 36 Press 66.500   3.325 Do Not Test   
30 Control vs 30 Press 26.500   1.968 Do Not Test   
30 Press vs 6 Control  154.500  5.823 Yes   
30 Press vs 6 Press  56.000   2.800 Do Not Test   
30 Press vs 36 Press  40.000   2.970 Do Not Test   
36 Press vs 6 Control  114.500  5.725 Yes   
36 Press vs 6 Press  16.000   1.188 Do Not Test   
6 Press vs 6 Control  98.500   7.315 Yes   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 438852.000 187860.000 694278.000  
30 Control 8 0 793680.000 700350.000 907126.500  
 
T = 41.500  n(small)= 8  n(big)= 8  P(est.)= 0.006  P(exact)= 0.003 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = 0.003) 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 438852.000 187860.000 694278.000  
36 Control 8 0 757482.000 719950.000 802956.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 793680.000 700350.000 907126.500  
36 Control 8 0 757482.000 719950.000 802956.000  
 
T = 68.000  n(small)= 8  n(big)= 8  P(est.)= 0.958  P(exact)= 1.000 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 1.000) 
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P-JNK 
 
One Way Analysis of Variance p-JNK  
Normality Test: Passed (P > 0.050) 
Equal Variance Test: Failed (P = <0.001) 
Test execution ended by user request, ANOVA on Ranks begun 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
Group N  Missing  Median    25%      75%     
6 Control 8 0 885725.000 801923.500 985779.000  
6 Press 8 0 1351094.500 1305436.000 1392464.000  
30 Control 8 0 1105104.000 975330.000 1236414.000  
30 Press 8 0 1338440.000 1311654.000 1372380.500  
36 Control 8 0 1013380.500 987492.000 1067133.000  
36 Press 8 0 882000.000 834695.000 892810.000  
 
H = 39.286 with 5 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
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All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison Diff of Ranks q P<0.05   
6 Press vs 36 Press 260.000 6.566 Yes   
6 Press vs 6 Control 242.000 7.319 Yes   
6 Press vs 36 Control 149.500 5.634 Yes   
6 Press vs 30 Control 132.500 6.625 Yes   
6 Press vs 30 Press 8.000 0.594 No   
30 Press vs 36 Press 252.000 7.621 Yes   
30 Press vs 6 Control 234.000 8.819 Yes   
30 Press vs 36 Control 141.500 7.075 Yes   
30 Press vs 30 Control 124.500 9.246 Yes   
30 Control vs 36 Press 127.500 4.805 Yes   
30 Control vs 6 Control 109.500 5.475 Yes   
30 Control vs 36 Control 17.000 1.262 No   
36 Control vs 36 Press 110.500 5.525 Yes   
36 Control vs 6 Control 92.500 6.869 Yes   
6 Control vs 36 Press 18.000 1.337 No   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 885725.000 801923.500 985779.000  
6 Press 8 0 1351094.500 1305436.000 1392464.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 1105104.000 975330.000 1236414.000  
30 Press 8 0 1338440.000 1311654.000 1372380.500  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Passed (P = 0.151) 
 
Group Name N  Missing Mean Std Dev SEM  
36 Control 8 0 1021420.875 54108.948 19130.402  
36 Press 8 0 869462.125 31129.192 11005.831  
 
Difference 151958.750 
 
t = 6.885 with 14 degrees of freedom. (P = <0.001) 
 
95 percent confidence interval for difference of means: 104622.544 to 199294.956 
 
The difference in the mean values of the two groups is greater than would be expected by 
chance; there is a statistically significant difference between the input groups (P = 
<0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
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t-test  
 
Normality Test: Failed (P = 0.010) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 885725.000 801923.500 985779.000  
30 Control 8 0 1105104.000 975330.000 1236414.000  
 
T = 45.500  n(small)= 8  n(big)= 8  P(est.)= 0.021  P(exact)= 0.015 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = 0.015) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 885725.000 801923.500 985779.000  
36 Control 8 0 1013380.500 987492.000 1067133.000  
 
T = 44.500  n(small)= 8  n(big)= 8  P(est.)= 0.016  P(exact)= 0.010 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = 0.010) 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 1105104.000 975330.000 1236414.000  
36 Control 8 0 1013380.500 987492.000 1067133.000  
 
T = 77.000  n(small)= 8  n(big)= 8  P(est.)= 0.372  P(exact)= 0.382 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 0.382) 
 
 
 
 
 
Kevin M. Rice Page 123 4/22/2005  
 
P38  
 
One Way Analysis of Variance  
Normality Test: Passed (P > 0.050) 
Equal Variance Test: Failed (P = <0.001) 
Test execution ended by user request, ANOVA on Ranks begun 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
Group N  Missing  Median    25%      75%     
6 Control 8 0 26627.500 22352.000 33383.000  
6 Press  8 0 32368.000 31307.500 32704.000  
30 Control 8 0 50210.000 38608.000 63007.500  
30 Press 8 0 54418.000 49855.000 57792.000  
36 Control 8 0 30432.000 24186.000 36630.000  
36 Press 8 0 31367.000 26832.000 36369.000  
 
H = 32.354 with 5 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
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All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison   Diff of Ranks  q P<0.05  
30 Press vs 6 Control  233.000  5.884 Yes   
30 Press vs 6 Press  181.000  5.474 Yes   
30 Press vs 36 Control 178.500  6.727 Yes   
30 Press vs 36 Press  173.500  8.675 Yes   
30 Press vs 30 Control 2.000   0.149 No   
30 Control vs 6 Control 231.000  6.986 Yes   
30 Control vs 6 Press  179.000  6.746 Yes   
30 Control vs 36 Control 176.500  8.825 Yes   
30 Control vs 36 Press 171.500  12.736 Yes   
36 Press vs 6 Control  59.500   2.242 No   
36 Press vs 6 Press  7.500   0.375 Do Not Test   
36 Press vs 36 Control 5.000   0.371 Do Not Test   
36 Control vs 6 Control 54.500   2.725 Do Not Test   
36 Control vs 6 Press  2.500   0.186 Do Not Test   
6 Press vs 6 Control  52.000   3.862 Do Not Test   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 26627.500 22352.000 33383.000  
30 Control 8 0 50210.000 38608.000 63007.500  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Failed (P = 0.002) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 26627.500 22352.000 33383.000  
36 Control 8 0 30432.000 24186.000 36630.000  
 
T = 52.500  n(small)= 8  n(big)= 8  P(est.)= 0.115  P(exact)= 0.105 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 0.105) 
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t-test  
 
Normality Test: Failed (P = 0.047) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 50210.000 38608.000 63007.500  
36 Control 8 0 30432.000 24186.000 36630.000  
 
T = 98.000  n(small)= 8  n(big)= 8  P(est.)= 0.002  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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p-p38 
One Way Analysis of Variance  
Normality Test: Passed (P > 0.050) 
Equal Variance Test: Failed (P = <0.001) 
Test execution ended by user request, ANOVA on Ranks begun 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 51650.000 47540.000 54060.000  
6 Press  8 0 216452.000 207268.000 218196.000  
30 Control 8 0 115674.000 114240.000 119806.000  
30 Press 8 0 232044.000 212160.000 251030.000  
36 Control 8 0 103020.000 82560.000 117416.000  
36 Press 8 0 143960.000 138216.000 157884.000  
 
H = 43.560 with 5 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
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All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison   Diff of Ranks  q P<0.05  
30 Press vs 6 Control  301.000  7.601 Yes   
30 Press vs 36 Control 218.500  6.608 Yes   
30 Press vs 30 Control 191.500  7.217 Yes   
30 Press vs 36 Press  109.000  5.450 Yes   
30 Press vs 6 Press  26.000   1.931 No   
6 Press vs 6 Control  275.000  8.317 Yes   
6 Press vs 36 Control  192.500  7.255 Yes   
6 Press vs 30 Control  165.500  8.275 Yes   
6 Press vs 36 Press  83.000   6.164 Yes   
36 Press vs 6 Control  192.000  7.236 Yes   
36 Press vs 36 Control 109.500  5.475 Yes   
36 Press vs 30 Control 82.500   6.127 Yes   
30 Control vs 6 Control 109.500  5.475 Yes   
30 Control vs 36 Control 27.000   2.005 No   
36 Control vs 6 Control 82.500   6.127 Yes   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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t-test  
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Passed (P = 0.189) 
 
Group Name  N  Missing Mean  Std Dev SEM  
6 Control 8 0  51062.500 4380.299 1548.669  
6 Press  8 0  214539.000 12168.622 4302.258  
 
Difference -163476.500 
 
t = -35.752 with 14 degrees of freedom. (P = <0.001) 
 
95 percent confidence interval for difference of means: -173283.547 to -153669.453 
 
The difference in the mean values of the two groups is greater than would be expected by 
chance; there is a statistically significant difference between the input groups (P = 
<0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 115674.000 114240.000 119806.000  
30 Press 8 0 232044.000 212160.000 251030.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = 0.027) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
36 Control 8 0 103020.000 82560.000 117416.000  
36 Press 8 0 143960.000 138216.000 157884.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Passed (P = 0.732) 
 
Group Name  N  Missing Mean  Std Dev SEM  
6 Control 8 0  51062.500 4380.299 1548.669  
30 Control 8 0  116755.000 3562.867 1259.664  
 
Difference -65692.500 
 
t = -32.907 with 14 degrees of freedom. (P = <0.001) 
 
95 percent confidence interval for difference of means: -69974.092 to -61410.908 
 
The difference in the mean values of the two groups is greater than would be expected by 
chance; there is a statistically significant difference between the input groups (P = 
<0.001). 
 
Power of performed test with alpha = 0.050: 1.000 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 51650.000 47540.000 54060.000  
36 Control 8 0 103020.000 82560.000 117416.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
 
 
 
 
 
Kevin M. Rice Page 135 4/22/2005  
t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 115674.000 114240.000 119806.000  
36 Control 8 0 103020.000 82560.000 117416.000  
 
T = 81.500  n(small)= 8  n(big)= 8  P(est.)= 0.172  P(exact)= 0.161 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 0.161) 
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P44/42 MAPK (ERK 1/2) 
 
One Way Analysis of Variance  
Normality Test: Passed (P > 0.050) 
Equal Variance Test: Failed (P = <0.001) 
 
Test execution ended by user request, ANOVA on Ranks begun 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 692464.500 582973.500 796461.000  
6 Press  8 0 742219.500 686992.500 821430.000  
30 Control 8 0 737685.000 649112.000 823394.500  
30 Press 8 0 767653.500 647040.000 889064.000  
36 Control 8 0 711841.500 706288.500 719833.000  
36 Press 8 0 776169.000 776169.000 778410.000  
 
H = 3.487 with 5 degrees of freedom.  (P = 0.625) 
 
The differences in the median values among the treatment groups are not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference    (P = 0.625) 
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t-test 
 
Normality Test: Failed (P = 0.004) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 692464.500 582973.500 796461.000  
30 Control 8 0 737685.000 649112.000 823394.500  
 
T = 52.000  n(small)= 8  n(big)= 8  P(est.)= 0.104  P(exact)= 0.105 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 0.105) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 692464.500 582973.500 796461.000  
36 Control 8 0 711841.500 706288.500 719833.000  
 
T = 68.000  n(small)= 8  n(big)= 8  P(est.)= 0.958  P(exact)= 1.000 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 1.000) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 737685.000 649112.000 823394.500  
36 Control 8 0 711841.500 706288.500 719833.000  
 
T = 68.000  n(small)= 8  n(big)= 8  P(est.)= 0.958  P(exact)= 1.000 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 1.000) 
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p-P44/42 MAPK (ERK 1/2) 
One Way Analysis of Variance 
Normality Test: Failed (P = <0.001) 
Test execution ended by user request, ANOVA on Ranks begun 
Kruskal-Wallis One Way Analysis of Variance on Ranks  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 637560.000 621565.000 653640.000  
6 Press 8 0 809137.000 799452.000 819451.000  
30 Control 8 0 434844.000 400352.000 477000.000  
30 Press 8 0 757044.000 615856.000 902697.000  
36 Control 8 0 472632.000 462990.000 475922.000  
36 Press 8 0 657720.000 492744.000 842284.000  
 
H = 33.517 with 5 degrees of freedom.  (P = <0.001) 
 
The differences in the median values among the treatment groups are greater than would 
be expected by chance; there is a statistically significant difference (P = <0.001) 
 
To isolate the group or groups that differ from the others use a multiple comparison 
procedure. 
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All Pairwise Multiple Comparison Procedures (Student-Newman-Keuls Method) : 
 
Comparison Diff of Ranks q P<0.05   
6 Press vs 30 Control 237.000 5.985 Yes   
6 Press vs 36 Control 219.000 6.623 Yes   
6 Press vs 6 Control 70.500 2.657 No   
6 Press vs 36 Press 56.000 2.800 Do Not Test   
6 Press vs 30 Press 17.500 1.300 Do Not Test   
30 Press vs 30 Control 219.500 6.638 Yes   
30 Press vs 36 Control 201.500 7.594 Yes   
30 Press vs 6 Control 53.000 2.650 Do Not Test   
30 Press vs 36 Press 38.500 2.859 Do Not Test   
36 Press vs 30 Control 181.000 6.822 Yes   
36 Press vs 36 Control 163.000 8.150 Yes   
36 Press vs 6 Control 14.500 1.077 Do Not Test   
6 Control vs 30 Control 166.500 8.325 Yes   
6 Control vs 36 Control 148.500 11.028 Yes   
36 Control vs 30 Control 18.000 1.337 No   
 
 
Note: The multiple comparisons on ranks do not include an adjustment for ties. 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = 0.007) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 637560.000 621565.000 653640.000  
6 Press 8 0 809137.000 799452.000 819451.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 434844.000 400352.000 477000.000  
30 Press 8 0 757044.000 615856.000 902697.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test 
 
Normality Test: Failed (P = 0.025) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
36 Control 8 0 472632.000 462990.000 475922.000  
36 Press 8 0 657720.000 492744.000 842284.000  
 
T = 36.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 637560.000 621565.000 653640.000  
30 Control 8 0 434844.000 400352.000 477000.000  
 
T = 100.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test 
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test 
 
Group N  Missing  Median    25%      75%     
6 Control 8 0 637560.000 621565.000 653640.000  
36 Control 8 0 472632.000 462990.000 475922.000  
 
T = 100.000  n(small)= 8  n(big)= 8  P(est.)= <0.001  P(exact)= <0.001 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (P = <0.001) 
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t-test  
 
Normality Test: Passed (P > 0.050) 
 
Equal Variance Test: Failed (P = <0.001) 
 
 
Test execution ended by user request, Rank Sum Test begun 
 
Mann-Whitney Rank Sum Test  
 
Group N  Missing  Median    25%      75%     
30 Control 8 0 434844.000 400352.000 477000.000  
36 Control 8 0 472632.000 462990.000 475922.000  
 
T = 59.000  n(small)= 8  n(big)= 8  P(est.)= 0.372  P(exact)= 0.382 
 
The difference in the median values between the two groups is not great enough to 
exclude the possibility that the difference is due to random sampling variability; there is 
not a statistically significant difference  (P = 0.382) 
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Table of Measures 
Systeme Internationale (SI) Unit Chart - International System of weights and measures. 
Yotto  [Y] 1,000,000,000,000,000,000,000,000  = 1x10 24
Zeta [Z] 1,000,000,000,000,000,000,000  = 1x10 21
Exa [E] 1,000,000,000,000,000,000   = 1x10 18
Peta [P] 1,000,000,000,000,000   = 1x10 15
Tera [T] 1,000,000,000,000    = 1x10 12
Giga [G] 1,000,000,000     = 1x10 9
Mega [G] 1,000,000     = 1x10 6
Kilo [k] 1,000      = 1x10 3 
Hecto [h] 100      = 1x10 2 
Deca [da] 10      = 1x10 1 
basic unit 1      = 1
Deci [d] 0.1      = 1x10 -1 
Centi [c] 0.01      = 1x10 -2 
Milli [m] 0.001      = 1x10 -3 
Micro [µ] 0.000 001     = 1x10 -6 
Nano [n] 0.000 000 001      = 1x10 -9 
Pico [p] 0.000 000 000 001    = 1x10 -12 
Femto [f] 0.000 000 000 000 001   = 1x10 -15 
Atto [a] 0.000 000 000 000 000 001   = 1x10 -18 
Zepto [z] 0.000 000 000 000 000 001   = 1x10 -21 
Yocto [y] 0.000 000 000 000 000 001   = 1x10 -24
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Basic SI units 
Category    Name   Abbreviation 
Length     meter    m 
 Mass     gram    g 
 Time     second    s 
 Electric current   ampere   A 
 Temperature    kelvin    K 
 Temperature    Celsius   C 
 Amount of substance    mole    mol 
 Luminous intensity   candela   cd 
 Electrical capacitance   farad    F 
 Frequency    hertz    Hz 
 Energy (work)    joule    J 
 Force     newton   N 
 Electrical conductor resistance ohm    Ω 
 Pressure generated by force  pascal    Pa 
 Electric potential   volt    V 
 Power or rate of work   watt    W 
 Speed  
 Volume    liter    L 
 
 
 
Kevin M. Rice Page 151 4/22/2005  
Metric System of Measurements 
 
Length 
10 millimeters (mm) = 1 centimeter (cm) 
10 centimeters (cm)  = 1 decimeter (dm) 
10 decimeters (dm)  = 1 meter (m) 
10 meters (m)          = 1 decameter (dam) 
10 decameters(dam)= 1 hectometer (hm) 
10 hectometers(hm) = 1 kilometer (km) 
1,000 meters (m)      = 1 kilometer (km) 
Volume 
1,000 cubic mm        = 1 cubic cm 
1,000 cubic cm         = 1 cubic dm 
1,000 cubic dm        = 1 cubic meter 
1 million cm 3          = 1 cubic meter 
Capacity 
10 milliliters (mL)    = 1 centiliter (cL) 
10 centiliter (cL)      = 1 deciliter (dL) 
10 deciliters (dL)     = 1 liter (L) 
1,000 liters (L)        = 1 m 3
 
Area 
100 square mm         = 1 square cm 
10,000 cm 2               = 1 m 2
100 m 2                     = 1 are 
100 ares          = 1 hectare 
10,000 m 2               = 1 hectare 
100 hectares         = 1 km 2
1,000,000 m 2          = 1 sq. 
Mass 
1,000 grams (g)         = I kilogram (kg) 
1,000 kilograms (kg) = 1 tonne 
 
Time 
1 minute (min)         = 60 seconds (s) 
1 hour (h)          = 60 minutes (min) 
1 day (d)                  = 24 hours (h) 
1 week (wk)            = 7 days (d) 
1 year (a)                = 12 months (mo) 
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The UK (imperial) System of Measurements 
Length 
12 inches                   = 1 foot 
3 feet                         = 1 yard 
22 yards                     = 1 chain 
10 chains                   = 1 furlong 
8 furlongs                  = 1 mile 
5,280 feet                  = 1 mile 
1,760 yards               = 1 mile 
Volume 
1,728 cubic inches       = 1 cubic foot 
27 cubic feet    = 1 cubic yard  
Mass 
437.5 grains      = 1 ounce 
16 ounces          = 1 pound (7,000 grains) 
14 pounds          = 1 stone 
8 stones          = 1 hundredweight [cwt] 
20 cwt            = 1 ton (2,240 pounds)  
Area 
144 square inches    = 1 square foot 
9 square feet            = 1 square yard 
4,840 square yards  = 1 acre 
640 acres                 = 1 square mile 
 
Capacity 
20 fluid ounces       = 1 pint 
4 gills                      = 1 pint 
2 pints                     = 1 quart 
4 quarts                   = 1 gallon (8 pints) 
Troy Weights 
24 grains              = 1 pennyweight 
20 pennyweights  = 1 ounce (480 grains) 
12 ounces          = 1 pound (5,760 grains) 
Apothecaries’ Measures 
20 minims              = 1 fluid scruple 
3 fluid scruples      = 1 fluid drachm 
8 fluid drachms     = 1 fluid ounce 
20 fluid ounces     = 1 pint 
Apothecaries’ Weights 
20 grains             = 1 scruple 
3 scruples            = 1 drachm 
8 drachms            = 1 ounce (480 grains) 
12 ounces            = 1 pound 
Conversions 
1 yard = 0.9144 meters –same as U.S. 
1 pound = 0.453 593 37 kg-same as U.S. 
1 gallon = 4.536 09 liters-different U.S
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The US System of Measurements
Length 
12 inches                   = 1 foot 
3 feet                         = 1 yard 
220 yards                  = 1 furlong 
8 furlongs                  = 1 mile 
5,280 feet                  = 1 mile 
1,760 yards               = 1 mile 
Volume 
1,728 cubic inches       = 1 cubic foot 
27 cubic feet    = 1 cubic yard  
Mass 
437.5 grains      = 1 ounce 
16 ounces          = 1 pound (7,000 grains) 
14 pounds          = 1 stone 
100 pounds       = 1 hundredweight [cwt] 
20 cwt            = 1 ton (2,000 pounds) 
Capacity (Liquid) 
16 fluid ounces       = 1 pint 
4 gills                      = 1 pint 
2 pints                     = 1 quart 
4 quarts                   = 1 gallon (8 pints) 
  
Area 
144 square inches    = 1 square foot 
9 square feet            = 1 square yard 
4,840 square yards  = 1 acre 
640 acres                 = 1 square mile 
1 square mile          = 1 section 
36 section                 = township 
Troy Weights 
24 grains              = 1 pennyweight 
20 pennyweights  = 1 ounce (480 grains) 
12 ounces          = 1 pound (5,760 grains) 
Apothecaries’ Measures 
60 minims              = 1 fluid dram 
8 fluid drams         = 1 fluid ounce 
16 fluid ounces     = 1 pint 
Apothecaries’ Weights 
20 grains             = 1 scruple 
3 scruples            = 1 dram 
8 drams               = 1 ounce (480 grains) 
12 ounces            = 1 pound 
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Capacity (Dry) 
2 pints                     = 1 quart 
8 quarts         = 1 peck 
4 pecks                   = 1 bushel 
 
Conversions 
1 yard = 0.9144 meters –same as UK 
1 pound = 0.453 593 37 kg-same as UK 
1gallon=3.785411784litersdifferentUK 
1 bushel = 35.239 070 166 88 liters
  
Conversions 
Length 
1 m   = 100 cm 
1 m   = 1.0936 yards (yd) 
1 cm  = 0.3937 inches (in) 
1 inch (in)  = 2.54 cm exactly 
1 inch (in)  = 0.0254 km 
1 angstrom (Ǻ) = 10 -8 cm 
1 mile    = 1.6093 km 
Time 
1 day (d)  = 86,400 s 
1 hour (hr)  = 3,600 s 
1 minute (min) = 60 s 
1 day (d)  = 1,440 min 
1 year  = 525,600 min 
1 year   = 31,536,000 s 
 
Mass 
1 kg   = 1,000 g 
1 kg   = 2.205 pounds (lb) 
1 lb   = 453.6 g 
1atomic mass unit(amu)=1.66054x10-24g 
 
Temperature 
0 K   = -273.15 ° Celsius (C) 
0 K   = -459.67° Fahrenheit (F) 
° F   = (9/5) ° C + 23 °  
° C   = (5/9) (° F - 23 °)   
K   = ° C + 273.15 
° C   = K – 273.15 
° F   = K – 459.67  
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Volume (derived) 
1 L   = 10-3 m 3
1 L   = 1.057 quarts (qt) 
1 in. 3   = 16.4 cm 3
1 cm 3   = 1 mL 
Force (derived) 
Newton           (N = m-kg/s2) 
1 dyne (dyn)    = 10 -5 N 
Pressure (derived) 
Pascal            (Pa =N/m2) 
1 atmosphere (atm) = 101,325 Pa 
1 atm          = 760 mm Hg 
1 atm          = 14.70 b/in.2
1 atm       = 1.013x10 6 dyn/cm2
Energy (derived) 
Joule                              (J=N-m) 
1 calorie (cal)                 = 4.184 J 
1 electron volt (eV)       = 96.485 kJ/mol 
1 liter-atmosphere (L-atm) = 101.325 J 
1 J      = 10 7 ergs 
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Index 
actin, 14, 22, 85 
activation, 9, 13, 14, 17, 22, 25, 28, 29, 
34, 43, 44, 47, 68, 69, 70, 71, 77, 78, 
79, 81, 82, 83, 85, 86, 87, 90, 91, 190, 
193 
age-associated, 11, 14, 16, 20, 24, 25, 
31, 40, 42, 43, 47, 67, 68, 69, 70, 85, 
86 
aging, 9, 10, 11, 14, 16, 17, 20, 22, 24, 
26, 28, 29, 30, 31, 33, 40, 43, 45, 57, 
67, 68, 69, 70, 71, 74, 75, 77, 80, 81, 
82, 86, 87, 88, 90, 193 
aortic vessel, 12, 47, 55 
architecture, 12, 22, 68 
artery, 10, 25, 35, 47, 75 
Brown Norway, 9, 11, 24, 29, 32, 33, 48, 
50, 51, 52, 72, 77, 81 
cardiomyocytes, 13, 23 
cardiovascular, 9, 10, 11, 14, 20, 24, 26, 
29, 31, 67, 73, 78, 80, 81 
Cardiovascular diseases 
CVD, 10 
cascades, 13, 23, 72, 73 
characteristics, 11, 74 
chondrocytes, 13, 22, 78, 91 
chronological, 11 
collagen, 25 
congestive heart failure, 10 
coronary, 10 
CVD. See cardiovascular desease, 
disease, 10, 11, 20, 24, 31, 72 
diseases, 10, 11, 20, 31, 73, 78 
elastin, 25 
endothelial, 13, 20, 23, 24, 46, 71, 76, 
83, 87, 92 
epidemic, 10 
ERK 1/2, 9, 13, 16, 29, 40, 41, 43, 45, 
52, 59, 60, 67, 71, 106, 107, 108, 110, 
111, 112, 114, 115, 117, 118, 119, 
120, 122, 123, 124, 125, 126, 127, 
154, 158 
expression, 2, 9, 13, 16, 17, 23, 25, 29, 
33, 34, 36, 38, 39, 40, 43, 45, 52, 59, 
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67, 72, 75, 77, 79, 82, 83, 85, 88, 172, 
174, 193 
extracellular signal-regulated kinase, 9, 
13, 16, 23, 29, 77, 81, 84 
F1 hybrid. See Fischer 344 X Brown 
Norway 
Fisher 344 
F344, 11, 31, 33, 73, 74 
forces, 12, 22, 69, 73, 87 
function, 9, 11, 14, 20, 22, 24, 26, 29, 
31, 33, 43, 46, 74, 81, 88, 89, 169 
gene, 13, 23, 33, 69, 72, 76, 77, 83 
Gerontological, 11 
hypertension, 10, 20, 42, 45, 47, 88, 91 
hypertensive, 14, 36, 43, 194 
incidence, 10 
infectious disease, 11 
intraluminal, 2, 9, 13, 17, 23, 29, 33, 36, 
39, 41, 55, 69, 70, 83 
lesion, 11 
mammalian, 13, 23, 81 
mechanical, 2, 12, 13, 14, 20, 22, 23, 24, 
32, 33, 42, 43, 44, 68, 69, 79, 80, 83, 
91, 92, 190 
mechanisms, 11, 13, 15, 17, 20, 22, 46, 
68, 69, 76 
mechanocytes, 13, 22 
mechanosensitive, 14, 22, 69 
mechanotransduction, 15, 22, 24, 30, 33, 
68, 74, 78, 79, 186 
mechanotrasduction, 12, 69 
metabolic, 12, 22 
Mitogen-activated protein kinase, 13, 78, 
80, 91 
model, 12, 14, 17, 19, 20, 24, 26, 32, 36 
morphology, 9, 11, 26, 29, 33, 39, 43 
Mortality, 11 
osteocytes, 13, 22, 85 
p42/44, 13, 16, 23, 193 
pathological, 11, 16, 68 
pathophysiologic, 11 
patients, 11 
perturbation, 11 
phenomena, 11 
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phosphorylation, 2, 9, 14, 17, 23, 25, 29, 
33, 38, 39, 40, 41, 43, 44, 51, 52, 60, 
62, 64, 67, 69, 85, 86, 87, 88 
physiology, 21, 78 
pressure, 9, 12, 13, 17, 24, 29, 32, 33, 
34, 36, 39, 40, 41, 42, 43, 44, 47, 48, 
55, 67, 68, 69, 70, 71, 83, 88, 91, 106, 
107, 108, 110, 111, 112, 114, 115, 
117, 118, 119, 120, 121 
prevalence, 10 
rats, 11, See Rat, 
SAPK, 13, 16 
Sensitivity, 12, 22 
signaling, 12, 13, 15, 16, 22, 23, 25, 32, 
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Curriculum Vitae 
Kevin Matthew Rice 
Office: Science Building 311, College of Science 
Marshall University - COS, 1 John Marshall Drive, Huntington, WV 25702 
304.696.3267 rice9@marshall.edu 
Home: 3326 County Rd. 73, Crown City, Oh 45623 
(740)256-1874 
Cell (304)638-2982 
ACADEMIC PREPARATION: 
M.S. in Biology,  
College of Science, Marshall University of West Virginia, Huntington, 2005  
Concentrations: Molecular Biology, Physiology  
Dissertation: EFFECTS OF AGING ON PRESSURE-INDUCED MAPK 
ACTIVATION IN THE RAT AORTA 
Advisor: Dr. Eric R. Blough 
 
Committee members: Dr Eric Blough, Dr. David Mallory, Dr. Nicoli Locassio  
 
In –Service Training Certificate, 
Common Pleas Court – Constable Division, Ohio,  
FBI Domestic and International Terrorism, and Weapons of Mass Destruction 
Seminar at Ohio University Southern Campus, Ironton, 2002  
 
Basic Spotter Training Certification,  
 
The National Weather Service (SKYWARN) 2002, 2 hours training 
 
B.A. in Psychology, Minor Biological Science, 
College of Arts and Sciences, Ohio University Southern Campus, Ironton, 1998  
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Concentrations: Educational Psychology, Developmental Psychology, Clinical 
and Experimental Psychology  
 
Confined Space Rescuer Training and Certification OSHA 29 CFR 1910.146,  
 
Hazardous Tek-knowledgies In. Heiner’s Bakery 1995 16 hours training 
 
 
Certified Bakery Maintenance Engineering,  
 
American Institute of Baking, Manhattan, Kansas, 1996 21.5 Continuing 
Education Units 
  
 Received training in: 
- Overall Baking industry 
- Mathematics 
o Basic Computations 
o Weights, measures, and formulas 
- Applied mechanics 
o Forces and energy 
o Solids, liquids, and gases 
o Heat and transfer 
- Basic electricity 
- Electrical energy and power 
- R C L Circuits 
- Electric motors and generators 
- Motor control 
- Basic electronics 
- Refrigeration 
- Refrigerants, accessories, and piping 
- Charging and troubleshooting a refrigeration system 
- Principles of hydraulics 
- Hydraulic components 
- Hydraulic components, operation and maintenance 
- Bearings and lubrication 
- Oxyacetylene welding and brazing 
- Arc welding, mig and tig gelding 
- Boilers 
- Bread processing equipment 
- Material handling equipment 
- Bakery ovens 
- Baking facility – machines and systems 
- Preventive maintenance 
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Certified Heating and Air-conditioning Mechanic,  
 
Lawrence County Vocational School, Chesapeake, OH, 1991  
 
Proficient in the following areas: 
- Design and layout of electrical circuits 
- Installing electrical components of the electrical trade 
- Repair and maintain electrical equipment 
- Apply all troubleshooting procedures 
- Use amprobe to check proper amperage 
- Use voltmeter to take proper colt readings 
- Use ohm meter to take proper resistance reagins 
- Identify an open electrical circuit 
- Identify a shorted electrical circuit 
- Read and understand basic wiring schematics 
- Correctly match wire sizes to their related amperage 
- Use good judgment in the repair of electrical equipment 
- Solder joints used in the residential plumbing 
- Use stick of sil-flos for commercial work 
-  Solder joint using 50/50, 95/5 staybrite or stick 
- Make flares or swedges used in working copper tubing 
- Cut and tread different types of pipe used in the field 
 
Layout and wire the following equipment: 
- Up-flow, down-flow and horizontal gas furnaces 
- Oil furnace 
- Electric furnaces 
- Split heat pump units 
- Electric water heaters  
- Window air conditioning 
- Freezers 
- Refrigerators 
- Package heat pumps 
- Central air conditioning  
- Sheet metal and duct work designs 
- Commercial refrigeration systems 
o Walk-in coolers 
o Walk-in Freezers 
o Etc. 
- Layout design air, gas, water, septic piping  
    
  
 
Course work in progress 
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Institute of Children’s Literature, West Redding, CT, at present 
 
Course work in progress 
 
International Bible College & Seminary, Independence, Missouri, at present 
 
Transferred course work to IBC&S,  
 
Kent Christian College, Dover, Delaware Attended in 1992. 
 
Ohio University Southern Campus  
 
Ironton, Ohio Study Skills Workshop 1998  
RESEARCH SKILLS: 
Proficient in: 
- Computer based statistics programs 
- Computer based data analysis software 
o Microsoft Office package software 
o Etc. 
- Figure generation and data presentation 
- Spot densitometry  
- Immunoblotting 
- Immunohistochemistry 
- Tissue sectioning 
- Cryostat operation and maintenance 
- Wet and dry mount slide preparation 
- Multiple tissue staining procedures 
- Gel electrophoresis 
- Cell culture 
o Passage  cell 
o Cell counting 
o Sterile conditions 
o Cell collection and storage  
o Preparing media and cell culture materials 
- Tissue preparation 
- Protein analysis 
- Cell and tissue lysis procedures 
- Designed and constructed vessel perfusion system 
- Small animal thoracic surgery  
- Skeletal muscle isolation 
- Development and evaluation research models and techniques  
- Microbiology media preparation 
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LANGUAGES: 
- Can read and speak some Spanish 
- Basic computer language 
- Cobol computer language 
- Pascal computer language 
- Visual Basic 
- Assembly computer language 
PROFESSIONAL EXPERIENCE: 
Research Assistant, spring 2005 
Dr. Eric Blough, Marshall University 
 
Teaching Assistant, fall 2004 
Faculty in Biology, Marshall University 
Courses:  
Microbiology  
 
Volunteer Research Assistant, fall 2004 
Faculty in Biology, Marshall University 
- Assisted Dr. Eric R. Blough on Cardiac Research Grant 
- Created mechanical device for mounting and pressurizing rat aortic section.  
Summer Research Assistant, Summer 2004 
Faculty in Biology, Marshall University 
- Assisted Dr. Eric R. Blough on Cardiac Research Grant 
- Collected and analyzed data, dealing with MAPK and p70S6k activation in rat 
aortic vascular smooth muscle.  
Volunteer Research Assistant, spring 2004 
Faculty in Biology, Marshall University 
- Assisted Dr. Eric R. Blough on Cardiac Research Grant 
- Maintained cell culture line of A7R5 vascular smooth muscle cells. 
- Collected and analyzed data, dealing with Fluprostenol activation of MAPK and 
p70S6k activation in A7R5 aortic vascular smooth muscle.  
 
Instructor, winter 2004 
Division of Continuing Education, Marshall Community & Technical College 
Courses:  
The Art of Crochet, and Intermediate Crocheting  
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Skilled Construction Worker 1998 - 2002 
Riedel Wilks Building Structures, Huntington, WV 
- Commercial construction 
- General plumbing  
- Electrical 
- Steel building erection 
-  Metal framework,  
- Conveyor systems design and 
installation for industry,  
- Mechanical equipment 
manufacturing 
- Welding 
- Conventional construction 
- Concrete work 
- Sight excavation 
- Building layout and design 
- Heavy equipment operation 
Backhoe, bulldozer, 
bobcat, front-end loader, 
fork truck,  
 
Merchandising Assistant 1997 - 1999 
J. C. Penny’s, Barbersville, WV 
- Department organization 
- Floor set up and display 
- Stock organization 
- Customer service  
 
Peer Adviser, 1997 
Director of Admissions, Admission Department 
Ohio University, Ironton, OH 
- Assisted Dr. Charles Jerret, Director of admission  
- Advised incoming students in course offerings and student financial aid 
- Developed programs to increase enrollment 
 
Tutor, 1997 
Faculty in all Departments 
Ohio University, Ironton, OH, Marshall University 
Courses:  
- Chemistry 
- Physics 
- Economics 
- Algebra 
- Psychology 
- Biology 
- General Math 
- Statistics  
 
 
PUBLICATIONS: 
- Effects of Aging on Pressure-Induced MAPK Activation in the Rat Aorta;  K. M. Rice1, 
R. S. Kinnard1, R. Harris2, 3, G. L. Wright3 and E. R. Blough1, 3 ; 1 Department of 
Biological Sciences, Marshall University, 2 Department of Biological Sciences, West 
Virginia State University, 3 Department of Physiology, Joan C. Edwards School of 
Medicine, Marshall University (Accepted by Pflüger’s Arch.) 
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RESEARCH SUBMITTED AND IN PREPARATION: 
 
- Effects of Aging on Tissue Content and Pressure-Induced Regulation of p70S6k in the 
Rat Aorta; K. M. Rice1, R. S. Kinnard1, G. L. Wright2, and E. R. Blough1,2 ; 1 Department 
of Biological Sciences, Marshall University, 2 Department of Physiology, Marshall 
University, Joan C. Edwards School of Medicine ( Currently in review at Mechanisms of 
Aging) 
 
-The Effects of Age on Muscle Physiology in Fischer 344 and Fischer 344 X Brown 
Norway Rats; Kevin M. Rice1, Jon K. Linderman2, Eric R. Blough1, 3 ; 1 Department of 
Biological Sciences, Marshall University, 2Department of Health and Sport Science, 
University of Dayton, 3 Department of Physiology, Joan C. Edwards School of Medicine,  
Marshall University (Currently in review with Canadian Journal of Physiology) 
 
- Prostaglandin F2α Signaling in A7R5 Hypertrophy. K. M. Rice1, S. Uddemarri 1, F. 
Chan1, R. S. Kinnard1, (R. Harris2,3), G. L. Wright3 and E. R. Blough1,3 ; 1 Department of 
Biological Sciences, Marshall University, 2 Department of Biological Sciences, West 
Virginia State University, 3 Department of Physiology, Joan C. Edwards School of 
Medicine, Marshall University (In preparation) 
 
- Effects of FP Agonist on MAPK Activation in the A7R5 Smooth Muscle Cell Line; 
Kevin M. Rice1, S. Uddemarri1, Randy Kinnard1, Robert Harris2, Gary Wright3 and Eric 
R. Blough1,3 ; 1 Department of Biological Sciences, Marshall University, 2 Department of 
Biological Sciences, West Virginia State University, 3 Department of Physiology, Joan C. 
Edwards School of Medicine, Marshall University (In preparation) 
 
- Effects of Aging on Pressure-Induced FAK Activation in the Rat Aorta. K. M. Rice1, R. 
S. Kinnard1, R. Harris2,3, G. L. Wright3 and E. R. Blough1,3 : 1 Department of Biological 
Sciences, Marshall University, 2 Department of Biological Sciences, West Virginia State 
University, 3 Department of Physiology, Joan C. Edwards School of Medicine, Marshall 
University  (In preparation) 
 
- Effects of Aging on Contractile properties  in the Aorta of Fischer 344 X Brown 
Norway Rats; K. M. Rice1, G. L. Wright2, and E. R. Blough1,2 ; 1 Department of 
Biological Sciences, Marshall University, 2 Department of Physiology, Marshall 
University, Joan C. Edwards School of Medicine (In preparation) 
 
- Effects of Aging on ROS Indices  in the Aorta of Fischer 344 X Brown Norway Rats; K. 
M. Rice1, G. L. Wright2, and E. R. Blough1,2 ; 1 Department of Biological Sciences, 
Marshall University, 2 Department of Physiology, Marshall University, Joan C. Edwards 
School of Medicine (In preparation) 
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PAPERS PRESENTED AT CONFERENCES: 
ERK-1/2 and p38 MAPK signaling in the A7R5 cell line following Fluprostenol 
stimulation. Kevin M. Rice1, Sreevani Uddemaari1, Devashish Desai3, Randy S. 
Kinnard1, Robert Harris2, G. L. Wright3, and E. R. Blough1, 3. 1Department of Biological 
Sciences, Marshall University, 2 Department of Biological Sciences, West Virginia State 
University, 3 Department of Physiology, Joan C. Edwards School of Medicine, Marshall 
University. To be Presented at the 52nd Annual Meeting of the American College of 
Sport Medicine(ACSM), Nashville, TN, 2005 
 
 
The PGF2α analog Fluprostenol activates mTOR and GSK-3β in the A7R5 smooth 
muscle cell line. Sreevani Uddemaari1, Kevin M. Rice1, Randy S. Kinnard1, Robert 
Harris2, G. L. Wright3, and E. R. Blough1, 3. 1Department of Biological Sciences, 
Marshall University, 2 Department of Biological Sciences, West Virginia State 
University, 3Department of Physiology, Joan C. Edwards School of Medicine, Marshall 
University.  To be Presented at the 52nd Annual Meeting of the American College of 
Sport Medicine, Nashville, TN, 2005 
 
Comparison between stretch-induced p42/44 MAPK signaling in rat aortic smooth 
muscle and A7R5 vascular cells. Devashish H. Desai, M.S.1, Robert T. Harris, Ph.D.2, 
Gary L. Wright, Ph.D.3, Kevin M. Rice, B.S.3, Deepak B. Mylabathula, M.B.B.S.3, Eric 
R. Blough, Ph.D.1,3.  1Department of Physiology, Marshall University School of 
Medicine, Huntington, WV;  2West Virginia State University, Charleston, WV;  
3Department of Biology, Marshall University, Huntington, WV. To be Presented at the 
52nd Annual Meeting of the American College of Sport Medicine, Nashville, TN, 2005 
 
Comparison between stretch-induced p42/p44 MAPK signaling in rat aortic smooth 
muscle and A7R5 vascular cells. Devashish H. Desai1, Robert T. Harris2, Gary L. 
Wright1, Kevin M. Rice3, Eric R Blotigh1,3, 1Department of Physiology, Marshall 
University School of Medicine, Huntington, WV;  2West Virginia State University, 
Charleston, WV;  3Department of Biology, Marshall University, Huntington, WV. 
Presented at the Marshall University School of Medicine Research Day, Huntington, 
WV, 2005  
 
Differential effects of aging on basal expression level and stretch-induced activation of 
ERK1/2 in rat soleus and EDL muscles. Kevin M. Rice1, Zihao Wang1, Deepak benjamin 
Mylabathula1, Eric R Blotigh1,2, 1Department of Biology, Marshall University, 311 
Science Building, One John Marshall Drive, Huntington, WV, 25702, Marshall 
University; 2Department of Physiology, Marshall University School of Medicine, 
Huntington, WV;  Presented at the Integrative Biology of Exercise International meeting 
of the American Physiological Society, the Canadian Society for Exercise Physiology, 
and the American College of Sports Medicine, Austin, TX, 2004  
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CURRENT RESEARCH INTERESTS: 
I am currently interested in researching the isolation of skeletal myocytes and 
development aortic replacement vessel from the isolated cells.  
 
I am currently investigating the biochemical responses of A7R5 vascular smooth muscle 
to prostaglandin F2α stimulation.  
 
Presently, I am looking at developing an aortic transplant developed from explants of 
skeletal muscle myocytes. 
 
I am currently performing a studying an alterations in molecular signaling in diabetic and 
non-diabetic aortas of Zuker rats exposed to a hypertensive pressure of 200 mm hg for 30 
min. 
 
I am currently performing a studying an alterations in molecular signaling in diabetic and 
non-diabetic vena cava of Zuker rats exposed to a systolic pressure of 120 mm hg for 30 
min. 
 
GRANTS RECEIVED: 
 Travel award from Marshall University – COS to attend the Integrative Biology 
of Exercise International meeting of the American Physiological Society, the Canadian 
Society for Exercise Physiology, and the American College of Sports Medicine, Austin, 
TX, 2004  
 
PROFESSIONAL MEMBERSHIPS: 
American College of Sport Medicine (ACSM)  
PROFESSIONAL SERVICE: 
- Founder and President, Campus Ministries International, Marshall University, 
2005 
- President, Graduate Student Council, Marshall University, 2004-2005 
 Reestablished this group after numerous years of non-existence  
 - Established cancer scarf drive 2005 
- Member of the Lawrence County ARES (Amateur Radio Emergency Services) 
1999 - Present 
- Member of the Lawrence County RACES (Radio Amateur Civil Emergency 
Services) 1999 - Present  
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- President, Student Government, Ohio University Southern Campus, 1997-98  
 - Developed numerous events and student activites which still occur to 
date 
- Vice President, Student Government, Ohio University Southern Campus, 1996-
1997  
- Tobacco Chair, American Cancer Society, Lawrence County Ohio Chapter, 
1996-1998  
- Member, Los Amigos Internacionales Club May 1997 – May 1998 
- President, Vocational Industrial Clubs of America (V.I.C.A.) Lawrence County 
Joint Vocational School (Now Collins Career Center) 1990-91   
- Chaplin, Vocational Industrial Clubs of America (V.I.C.A.) Lawrence County 
Joint Vocational School (Now Collins Career Center) 1989-90    
- Third place, VICA Regional HVAC competition 1990  
- Second place, VICA Regional HVAC competition 1991  
 
 COMMUNITY SERVICE: 
 
- Taught crochet at ladies groups at New Beginning Apostolic Church 2005 
- Church Librarian for 4 years  
- Church musician (Bass, guitar, keyboard, and singer) for 15+ years 
- Licensed Minister New Beginning Apostolic Church 2000-pressent 
- Evangelized intermittently for 14 years  
- Licensed Minister UPCI 1999-2000 
- Authority to Solemnize Marriages in the State of Ohio 1997- present 
- Licensed Minister Universal Life Church 1997- present 
- Leader BOYZ Club New Beginning Apostolic Church 1998-1999 
- Director of High Rise Ministry (Nursing Home) New Beginnings Apostolic 
Church 1998 - 1999 
- Assistant Director of High Rise Ministry (Nursing Home) New Beginnings 
Apostolic Church 1997 - October 1998 
- Pastor, New Life Apostolic Church, Scottown Ohio, 1997 –1998 
- Assistant to Pastor (during illness and recovery), Decator Apostolic Church, 
Decator, OH, 1996 –1997 
- Church Camp Staff Member, UPCI WV District youth camp, Point Pleasant, 
WV, 1995 –1996 
- Assistant to Teen Department Sunday school director, Apostolic Life Cathedral, 
Huntington, WV, 1995 –1996 
- Sunday school teacher, Apostolic Life Cathedral, Huntington, WV, 1993 –1995 
 
 
 
 
HONORS AND AWARDS: 
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Recognition Award for work in the 134th Lawrence County Memorial Day Parade 
Amateur Radio Operator and division leader  
Certificate of Effective Alter Working New Beginning Apostolic Church 2002 
Certificate of Completion Ohio Project Wild 1998 
Certificate of Achievement Los Amigos Internacionales 1998 
Certificate of Appreciation Apostolic Life Cathedral Sunday School Department 
1997 
Who's Who American Colleges and University's 1997-98  
Who's Who American Colleges and University's 1996-97  
Certificate of Appreciation Sunday School Music Ministry, Sunday School 
Department Apostolic Life Cathedral 1995 
Certificate of Appreciation Teacher’s Assistant Sunday School Department 
Apostolic Life Cathedral 1995 
Certificate of Recognition in Voice, Kent Christian College Music Department, 
Dover, DE 1992 
Presidential Scholarship Kent Christian College Dover, DE 1992 
Honor Award Fairland High School 1991 
Achievement Award Fairland/ Lawrence County Joint Vocational School, 
Certificate of Achievement for heating-ventilation/air conditioning 1991 
Award of Distinction, State Board of Education 1991 
Who's Who in American High Schools 1990-91  
Who's Who in American High Schools 1989-90  
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